Core-binding	B-protein
factor	I-protein
beta	I-protein
(	O
CBFbeta	B-protein
)	O
,	O
but	O
not	O
CBFbeta-smooth	B-protein
muscle	I-protein
myosin	I-protein
heavy	I-protein
chain	I-protein
,	O
rescues	O
definitive	O
hematopoiesis	O
in	O
CBFbeta	B-protein
-deficient	O
embryonic	B-cell_type
stem	I-cell_type
cells	I-cell_type
.	O

Core-binding	B-protein
factor	I-protein
beta	I-protein
(	O
CBFbeta	B-protein
)	O
is	O
the	O
non-DNA-binding	B-protein
subunit	I-protein
of	O
the	O
heterodimeric	B-protein
CBFs	I-protein
.	O

Genes	B-DNA
encoding	I-DNA
CBFbeta	I-DNA
(	O
CBFB	B-DNA
)	O
,	O
and	O
one	O
of	O
the	O
DNA-binding	B-protein
CBFalpha	I-protein
subunits	I-protein
,	I-protein
Runx1	I-protein
(	O
also	O
known	O
as	O
CBFalpha2	B-protein
,	O
AML1	B-protein
,	O
and	O
PEBP2alphaB	B-protein
)	O
,	O
are	O
required	O
for	O
normal	O
hematopoiesis	O
and	O
are	O
also	O
frequent	O
targets	O
of	O
chromosomal	O
translocations	O
in	O
acute	O
leukemias	O
in	O
humans	O
.	O

Homozygous	O
disruption	O
of	O
either	O
the	O
Runx1	B-DNA
or	I-DNA
Cbfb	I-DNA
gene	I-DNA
in	O
mice	O
results	O
in	O
embryonic	O
lethality	O
at	O
midgestation	O
due	O
to	O
hemorrhaging	O
in	O
the	O
central	O
nervous	O
system	O
,	O
and	O
severely	O
impairs	O
fetal	O
liver	O
hematopoiesis	O
.	O

Results	O
of	O
this	O
study	O
show	O
that	O
Cbfb-deficient	O
mouse	O
embryonic	B-cell_type
stem	I-cell_type
(	I-cell_type
ES	I-cell_type
)	I-cell_type
cells	I-cell_type
can	O
differentiate	O
into	O
primitive	B-cell_type
erythroid	I-cell_type
colonies	I-cell_type
in	O
vitro	O
,	O
but	O
are	O
impaired	O
in	O
their	O
ability	O
to	O
produce	O
definitive	O
erythroid	B-cell_type
and	I-cell_type
myeloid	I-cell_type
colonies	I-cell_type
,	O
mimicking	O
the	O
in	O
vivo	O
defect	O
.	O

Definitive	O
hematopoiesis	O
is	O
restored	O
by	O
ectopic	O
expression	O
of	O
full-length	B-DNA
Cbfb	I-DNA
transgenes	I-DNA
,	O
as	O
well	O
as	O
by	O
a	O
transgene	O
encoding	O
only	O
the	O
heterodimerization	B-protein
domain	I-protein
of	O
CBFbeta	B-protein
.	O

In	O
contrast	O
,	O
the	O
CBFbeta	B-protein
-	O
smooth	B-protein
muscle	I-protein
myosin	I-protein
heavy	I-protein
chain	I-protein
(	I-protein
SMMHC	I-protein
)	I-protein
fusion	I-protein
protein	I-protein
generated	O
by	O
the	O
inv	B-protein
(	I-protein
16	I-protein
)	I-protein
associated	O
with	O
acute	B-cell_line
myeloid	I-cell_line
leukemias	I-cell_line
(	O
M4Eo	B-cell_line
)	O
can	O
not	O
rescue	O
definitive	O
hematopoiesis	O
by	O
Cbfb-deficient	B-cell_type
ES	I-cell_type
cells	I-cell_type
.	O

Sequences	O
responsible	O
for	O
the	O
inability	O
of	O
CBFbeta	B-protein
-SMMHC	O
to	O
rescue	O
definitive	O
hematopoiesis	O
reside	O
in	O
the	O
SMMHC	B-protein
portion	I-protein
of	O
the	O
fusion	B-protein
protein	I-protein
.	O

Results	O
also	O
show	O
that	O
the	O
CBFbeta-SMMHC	B-protein
fusion	I-protein
protein	I-protein
transdominantly	O
inhibits	O
definitive	O
hematopoiesis	O
,	O
but	O
not	O
to	O
the	O
same	O
extent	O
as	O
homozygous	O
loss	O
of	O
Runx1	B-protein
or	O
Cbfb	B-protein
.	O

CBFbeta-SMMHC	B-protein
preferentially	O
inhibits	O
the	O
differentiation	O
of	O
myeloid	B-cell_type
lineage	I-cell_type
cells	I-cell_type
,	O
while	O
increasing	O
the	O
number	O
of	O
blastlike	B-cell_type
cells	I-cell_type
in	O
culture	O
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIESIS	NULL
Core-binding	NULL
factor	NULL
B	NULL
(	NULL
CBFB	NULL
)	NULL
,	NULL
but	NULL
not	NULL
CBFB-smooth	NULL
muscle	NULL
myosin	NULL
heavy	NULL
chain	NULL
,	NULL
rescues	NULL
definitive	NULL
hematopoiesis	NULL
in	NULL
CBFB-deficient	NULL
embryonic	NULL
stem	NULL
cells	NULL
Janelle	NULL
D.	NULL
Miller	NULL
,	NULL
Terry	NULL
!	NULL

Stacy	NULL
,	NULL
P.	NULL
Paul	NULL
Liu	NULL
,	NULL
and	NULL
Nancy	NULL
A.	NULL
Speck	NULL
Core-binding	NULL
factor	NULL
B	NULL
(	NULL
CBFRB	NULL
)	NULL
is	NULL
the	NULL
non-DNA-binding	NULL
subunit	NULL
of	NULL
the	NULL
heterodimeric	NULL
CBFs	NULL
.	NULL

Genes	NULL
encoding	NULL
CBFB	NULL
(	NULL
CBFB	NULL
)	NULL
,	NULL
and	NULL
one	NULL
of	NULL
the	NULL
DNA-binding	NULL
CBFa	NULL
«	NULL
subunits	NULL
,	NULL
Runx1	NULL
(	NULL
also	NULL
known	NULL
as	NULL
AML1	NULL
,	NULL
and	NULL
PEBP2	NULL
«	NULL
B	NULL
)	NULL
,	NULL
are	NULL
required	NULL
for	NULL
normal	NULL
hematopoiesis	NULL
and	NULL
are	NULL
also	NULL
frequent	NULL
targets	NULL
of	NULL
chromosomal	NULL
translocations	NULL
in	NULL
acute	NULL
leukemias	NULL
in	NULL
humans	NULL
.	NULL

Homozygous	NULL
disruption	NULL
of	NULL
either	NULL
the	NULL
Runx	NULL
?	NULL

or	NULL
Cbfb	NULL
gene	NULL
in	NULL
mice	NULL
results	NULL
in	NULL
embryonic	NULL
lethality	NULL
at	NULL
midgestation	NULL
due	NULL
to	NULL
hemorrhaging	NULL
in	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
,	NULL
and	NULL
severely	NULL
impairs	NULL
fetal	NULL
liver	NULL
hematopoiesis	NULL
.	NULL

Results	NULL
of	NULL
this	NULL
study	NULL
show	NULL
that	NULL
Cbfb-deficient	NULL
mouse	NULL
embryonic	NULL
stem	NULL
(	NULL
ES	NULL
)	NULL
cells	NULL
can	NULL
differentiate	NULL
into	NULL
primitive	NULL
erythroid	NULL
colonies	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
are	NULL
impaired	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
produce	NULL
definitive	NULL
erythroid	NULL
and	NULL
myeloid	NULL
colonies	NULL
,	NULL
mimicking	NULL
the	NULL
in	NULL
vivo	NULL
defect	NULL
.	NULL

Definitive	NULL
hematopoiesis	NULL
is	NULL
restored	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
full-length	NULL
Cbfb	NULL
transgenes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
a	NULL
transgene	NULL
encoding	NULL
only	NULL
the	NULL
heterodimerization	NULL
domain	NULL
of	NULL
CBFB	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
CBFB-smooth	NULL
muscle	NULL
myosin	NULL
heavy	NULL
chain	NULL
(	NULL
SMMHC	NULL
)	NULL
fusion	NULL
protein	NULL
generated	NULL
by	NULL
the	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
associated	NULL
with	NULL
acute	NULL
myeloid	NULL
leukemias	NULL
(	NULL
M4Eo	NULL
)	NULL
can	NULL
not	NULL
rescue	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
Cbfb-deficient	NULL
ES	NULL
cells	NULL
.	NULL

Sequences	NULL
responsible	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
CBFB-SMMHC	NULL
to	NULL
rescue	NULL
definitive	NULL
hematopoiesis	NULL
reside	NULL
in	NULL
the	NULL
SMMHC	NULL
portion	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
.	NULL

Results	NULL
also	NULL
show	NULL
that	NULL
the	NULL
CBFB-SMMHC	NULL
fusion	NULL
protein	NULL
transdominantly	NULL
inhibits	NULL
definitive	NULL
hematopoiesis	NULL
,	NULL
but	NULL
not	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
homozygous	NULL
loss	NULL
of	NULL
Runx1	NULL
or	NULL
Cbfb	NULL
.	NULL

CBFB-SMMHC	NULL
preferentially	NULL
inhibits	NULL
the	NULL
differentiation	NULL
of	NULL
myeloid	NULL
lineage	NULL
cells	NULL
,	NULL
while	NULL
increasing	NULL
the	NULL
number	NULL
of	NULL
blastlike	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

(	NULL
Blood	NULL
.	NULL

2001	NULL
;	NULL
97	NULL
:	NULL
2248-2256	NULL
)	NULL
©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
Introduction	NULL
Core-binding	NULL
factors	NULL
(	NULL
CBFs	NULL
)	NULL
are	NULL
heterodimeric	NULL
transcription	NULL
factors	NULL
consisting	NULL
of	NULL
a	NULL
DNA-binding	NULL
subunit	NULL
(	NULL
CBFa	NULL
)	NULL
and	NULL
a	NULL
non-DNA-binding	NULL
CBFB	NULL
subunit	NULL
.	NULL
'	NULL

>	NULL
Three	NULL
genes	NULL
in	NULL
mammals	NULL
encode	NULL
CBFa	NULL
subunits	NULL
(	NULL
Runxl	NULL
,	NULL
Runx2	NULL
,	NULL
Runx3	NULL
,	NULL
formerly	NULL
known	NULL
as	NULL
Chfa2	NULL
,	NULL
Chfal	NULL
,	NULL
and	NULL
Cbfa3	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
CBFB	NULL
subunit	NULL
is	NULL
encoded	NULL
by	NULL
one	NULL
gene	NULL
,	NULL
Chfb	NULL
.	NULL

'®	NULL
CBFRB	NULL
heterodimerizes	NULL
with	NULL
all	NULL
3	NULL
CBFa	NULL
subunits	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
this	NULL
interaction	NULL
has	NULL
been	NULL
shown	NULL
only	NULL
for	NULL
Runx1	NULL
.	NULL

Homozygous	NULL
disruption	NULL
of	NULL
either	NULL
the	NULL
gene	NULL
encoding	NULL
Runx1	NULL
or	NULL
CBFR	NULL
caused	NULL
identical	NULL
developmental	NULL
defects	NULL
,	NULL
indicating	NULL
that	NULL
both	NULL
subunits	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
Runx1-CBFB	NULL
heterodimer	NULL
to	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

``	NULL
*	NULL
>	NULL
The	NULL
CBFs	NULL
function	NULL
in	NULL
multiple	NULL
developmental	NULL
pathways	NULL
in	NULL
mammals	NULL
and	NULL
invertebrates	NULL
.	NULL

The	NULL
Drosophila	NULL
runt	NULL
gene	NULL
,	NULL
which	NULL
encodes	NULL
a	NULL
CBF	NULL
subunit	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
sex	NULL
determination	NULL
,	NULL
segmentation	NULL
,	NULL
and	NULL
neurogenesis	NULL
.	NULL

'*~	NULL
'	NULL
``	NULL
The	NULL
related	NULL
gene	NULL
lozenge	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
developmental	NULL
pathways	NULL
involving	NULL
the	NULL
eye	NULL
,	NULL
antenna	NULL
,	NULL
and	NULL
tarsal	NULL
claws	NULL
,	NULL
and	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
crystal	NULL
cells	NULL
,	NULL
a	NULL
lineage	NULL
of	NULL
blood	NULL
cells	NULL
in	NULL
the	NULL
fly	NULL
.	NULL
'	NULL

%	NULL
``	NULL
°	NULL
The	NULL
mammalian	NULL
Runx2	NULL
gene	NULL
is	NULL
required	NULL
for	NULL
bone	NULL
formation	NULL
,	NULL
``	NULL
and	NULL
both	NULL
Runx	NULL
!	NULL

and	NULL
Chfb	NULL
are	NULL
required	NULL
for	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL
``	NULL

Definitive	NULL
hematopoiesis	NULL
is	NULL
the	NULL
second	NULL
wave	NULL
of	NULL
hematopoiesis	NULL
in	NULL
the	NULL
developing	NULL
vertebrate	NULL
embryo	NULL
and	NULL
produces	NULL
hematopoietic	NULL
cells	NULL
of	NULL
the	NULL
lymphoid	NULL
,	NULL
myeloid	NULL
,	NULL
and	NULL
enucleated	NULL
(	NULL
definitive	NULL
)	NULL
erythroid	NULL
lineages	NULL
.	NULL

Definitive	NULL
hematopoiesis	NULL
is	NULL
preceded	NULL
by	NULL
primitive	NULL
erythropoiesis	NULL
,	NULL
which	NULL
occurs	NULL
in	NULL
the	NULL
yolk	NULL
sac	NULL
and	NULL
produces	NULL
a	NULL
transient	NULL
population	NULL
of	NULL
nucleated	NULL
primitive	NULL
erythrocytes	NULL
and	NULL
macro-phages	NULL
.	NULL

Progenitors	NULL
and	NULL
stem	NULL
cells	NULL
that	NULL
give	NULL
rise	NULL
to	NULL
the	NULL
definitive	NULL
hematopoietic	NULL
lineages	NULL
emerge	NULL
in	NULL
the	NULL
yolk	NULL
sac	NULL
,	NULL
the	NULL
para-aortic	NULL
splanchnopleure	NULL
,	NULL
the	NULL
vitelline	NULL
and	NULL
umbilical	NULL
arteries	NULL
,	NULL
and	NULL
in	NULL
the	NULL
aorta/genital	NULL
ridge/mesonephros	NULL
(	NULL
AGM	NULL
)	NULL
region	NULL
in	NULL
mammalian	NULL
embryos	NULL
.	NULL

``	NULL
``	NULL
>	NULL
5	NULL
Homozygous	NULL
disruption	NULL
of	NULL
or	NULL
Chfb	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
significantly	NULL
impair	NULL
the	NULL
first	NULL
stage	NULL
of	NULL
primitive	NULL
erythropoiesis	NULL
in	NULL
the	NULL
yolk	NULL
sac	NULL
,	NULL
but	NULL
blocks	NULL
the	NULL
second	NULL
wave	NULL
of	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL
``	NULL

RUNX1	NULL
(	NULL
AMLT	NULL
)	NULL
and	NULL
CBFB	NULL
are	NULL
frequent	NULL
targets	NULL
of	NULL
chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
leukemias	NULL
.	NULL
``	NULL

''	NULL
is	NULL
disrupted	NULL
by	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q22	NULL
;	NULL
q22	NULL
)	NULL
and	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
in	NULL
acute	NULL
myeloid	NULL
and	NULL
lymphocytic	NULL
leukemias,4	NULL
``	NULL
``	NULL
``	NULL
8	NULL
and	NULL
by	NULL
the	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
q22	NULL
)	NULL
and	NULL
t	NULL
(	NULL
16	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q24	NULL
;	NULL
q22	NULL
)	NULL
in	NULL
therapy-related	NULL
leukemias	NULL
and	NULL
myelodyspla-sias	NULL
.	NULL

``	NULL
``	NULL
4	NULL
``	NULL
CBFB	NULL
is	NULL
disrupted	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemias	NULL
by	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q22	NULL
)	NULL
,	NULL
t	NULL
(	NULL
16	NULL
;	NULL
16	NULL
)	NULL
,	NULL
and	NULL
del	NULL
(	NULL
16	NULL
)	NULL
(	NULL
q22	NULL
)	NULL
.	NULL
``	NULL

The	NULL
translocations	NULL
generate	NULL
chimeric	NULL
proteins	NULL
that	NULL
contain	NULL
all	NULL
or	NULL
part	NULL
of	NULL
Runx1	NULL
or	NULL
CBFB	NULL
fused	NULL
to	NULL
sequences	NULL
encoded	NULL
in	NULL
the	NULL
other	NULL
chromosomal	NULL
segment	NULL
involved	NULL
in	NULL
the	NULL
translocation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
inv'©	NULL
that	NULL
disrupts	NULL
CBFB	NULL
results	NULL
in	NULL
a	NULL
chimeric	NULL
protein	NULL
that	NULL
contains	NULL
most	NULL
of	NULL
the	NULL
CBFRB	NULL
protein	NULL
fused	NULL
to	NULL
the	NULL
C-terminal	NULL
«	NULL
-helical	NULL
rod	NULL
domain	NULL
from	NULL
a	NULL
smooth	NULL
muscle	NULL
myosin	NULL
heavy	NULL
chain	NULL
(	NULL
SMMHC	NULL
)	NULL
encoded	NULL
by	NULL
the	NULL
MYHI/	NULL
gene.©	NULL
Genetic	NULL
experiments	NULL
in	NULL
mice	NULL
demonstrated	NULL
that	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
transdominantly	NULL
inhibits	NULL
wild-type	NULL
Runx1	NULL
:	NULL
CBFB	NULL
function	NULL
in	NULL
vivo	NULL
,	NULL
in	NULL
that	NULL
mice	NULL
heterozygous	NULL
for	NULL
a	NULL
``	NULL
knocked-in	NULL
``	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
,	NULL
Hanover	NULL
,	NULL
NH	NULL
;	NULL
and	NULL
the	NULL
Oncogenesis	NULL
and	NULL
Development	NULL
Section	NULL
,	NULL
Genetics	NULL
and	NULL
Molecular	NULL
Biology	NULL
Branch	NULL
,	NULL
National	NULL
Human	NULL
Genome	NULL
Research	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
.	NULL

Submitted	NULL
June	NULL
28	NULL
,	NULL
2000	NULL
;	NULL
accepted	NULL
December	NULL
6	NULL
,	NULL
2000	NULL
.	NULL

N.A.S	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
RO1	NULL
CAS8343	NULL
and	NULL
CA75611	NULL
.	NULL

J.D.M	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
T32	NULL
Al	NULL
07363	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
2248	NULL
Health/Agency	NULL
for	NULL
International	NULL
Development	NULL
.	NULL

Reprints	NULL
:	NULL
Nancy	NULL
A.	NULL
Speck	NULL
,	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
,	NULL
Hanover	NULL
,	NULL
NH	NULL
03755	NULL
;	NULL
e-mail	NULL
:	NULL
nancy.speck	NULL
@	NULL
dartmouth.edu	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

Therefore	NULL
,	NULL
and	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
,	NULL
this	NULL
article	NULL
is	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
.	NULL

©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
CBFB-MYH11	NULL
allele	NULL
die	NULL
at	NULL
midgestation	NULL
from	NULL
essentially	NULL
the	NULL
same	NULL
defect	NULL
exhibited	NULL
by	NULL
mice	NULL
deficient	NULL
for	NULL
Runx	NULL
]	NULL
or	NULL
Chfb	NULL
.	NULL

*	NULL
'	NULL
Expression	NULL
of	NULL
a	NULL
CBFB-MYH11	NULL
transgene	NULL
in	NULL
myeloid	NULL
lineage	NULL
cells	NULL
impaired	NULL
neutrophilic	NULL
differentiation	NULL
and	NULL
this	NULL
effect	NULL
was	NULL
enhanced	NULL
by	NULL
an	NULL
activated	NULL
N-ras	NULL
oncogene	NULL
.	NULL
``	NULL

The	NULL
CBFB-SMMHC	NULL
protein	NULL
is	NULL
thought	NULL
to	NULL
transdominantly	NULL
inhibit	NULL
Runx1	NULL
:	NULL
CBFB	NULL
function	NULL
by	NULL
heterodimeriz-ing	NULL
with	NULL
RUNX1	NULL
and	NULL
sequestering	NULL
it	NULL
on	NULL
actin	NULL
filaments	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
``	NULL
``	NULL
4*	NULL
or	NULL
by	NULL
functioning	NULL
as	NULL
a	NULL
dedicated	NULL
transcriptional	NULL
repressor	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL
``	NULL

A	NULL
number	NULL
of	NULL
studies	NULL
have	NULL
demonstrated	NULL
the	NULL
utility	NULL
of	NULL
differentiating	NULL
mouse	NULL
embryonic	NULL
stem	NULL
(	NULL
ES	NULL
)	NULL
cells	NULL
in	NULL
vitro	NULL
to	NULL
study	NULL
hematopoi-esis	NULL
,	NULL
*°	NULL
and	NULL
showed	NULL
that	NULL
ES	NULL
cells	NULL
deficient	NULL
in	NULL
proteins	NULL
critical	NULL
for	NULL
hematopoiesis	NULL
in	NULL
the	NULL
embryo	NULL
often	NULL
show	NULL
similar	NULL
hematopoietic	NULL
impairments	NULL
in	NULL
vitro	NULL
.	NULL

For	NULL
example	NULL
,	NULL
GATA-1-deficient	NULL
ES	NULL
cells	NULL
fail	NULL
to	NULL
develop	NULL
primitive	NULL
erythroid	NULL
precursors	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
definitive	NULL
erythropoiesis	NULL
is	NULL
blocked	NULL
at	NULL
the	NULL
proerythroblast	NULL
stage	NULL
of	NULL
develop-ment	NULL
.	NULL

*	NULL
``	NULL
Ectopic	NULL
expression	NULL
of	NULL
GATA-I	NULL
transgenes	NULL
in	NULL
an	NULL
immature	NULL
erythroid	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
GATA-1-deficient	NULL
ES	NULL
cells	NULL
restored	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
in	NULL
vitro	NULL
.	NULL
``	NULL

SCL-deficient	NULL
ES	NULL
cells	NULL
fail	NULL
to	NULL
generate	NULL
either	NULL
primitive	NULL
or	NULL
definitive	NULL
hematopoietic	NULL
cells	NULL
of	NULL
all	NULL
lineages	NULL
,	NULL
and	NULL
this	NULL
defect	NULL
could	NULL
be	NULL
rescued	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
the	NULL
Sci	NULL
transgene.4	NULL
``	NULL
``	NULL
°	NULL
ES	NULL
cells	NULL
homozygous	NULL
for	NULL
deletion	NULL
of	NULL
PU	NULL
.	NULL
]	NULL

produce	NULL
no	NULL
detectable	NULL
myeloid	NULL
cells	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
expression	NULL
of	NULL
a	NULL
PU	NULL
.	NULL
]	NULL

transgene	NULL
restored	NULL
myelopoiesis	NULL
.	NULL
``	NULL

''	NULL
Runx1-deficient	NULL
ES	NULL
cells	NULL
can	NULL
not	NULL
produce	NULL
definitive	NULL
hematopoietic	NULL
progenitors	NULL
,	NULL
but	NULL
a	NULL
Runx	NULL
!	NULL

transgene	NULL
knocked	NULL
into	NULL
the	NULL
Runx1	NULL
locus	NULL
rescued	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL
``	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
Ch/b-deficient	NULL
ES	NULL
cells	NULL
undergo	NULL
primitive	NULL
erythropoiesis	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
are	NULL
impaired	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
undergo	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
Cbfb	NULL
transgenes	NULL
from	NULL
the	NULL
murine	NULL
stem	NULL
cell	NULL
virus	NULL
(	NULL
MSCV	NULL
)	NULL
restores	NULL
definitive	NULL
hematopoiesis	NULL
of	NULL
CBFRB-deficient	NULL
ES	NULL
cells	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
the	NULL
heterodimerization	NULL
domain	NULL
in	NULL
CBFRB	NULL
is	NULL
sufficient	NULL
for	NULL
its	NULL
function	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
CBFB-SMMHC	NULL
fusion	NULL
protein	NULL
is	NULL
unable	NULL
to	NULL
rescue	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
CBFB-deficient	NULL
ES	NULL
cells	NULL
,	NULL
and	NULL
thus	NULL
can	NULL
not	NULL
provide	NULL
CBFB	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
the	NULL
CBFBGB-SMMHC	NULL
protein	NULL
does	NULL
not	NULL
completely	NULL
impair	NULL
definitive	NULL
hematopoiesis	NULL
in	NULL
cells	NULL
containing	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
Chfb-MYH1T1	NULL
allele	NULL
and	NULL
one	NULL
wild-type	NULL
Chfb	NULL
allele	NULL
,	NULL
indicating	NULL
that	NULL
Runx1-CBFRB	NULL
function	NULL
is	NULL
not	NULL
completely	NULL
inhibited	NULL
by	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Retroviral	NULL
transfer	NULL
of	NULL
Cbfb	NULL
complementary	NULL
DNAs	NULL
to	NULL
ES	NULL
cells	NULL
'~	NULL
,	NULL
Cbfb	NULL
``	NULL
~	NULL
,	NULL
Cbfb	NULL
'~	NULL
,	NULL
and	NULL
ES	NULL
cells	NULL
were	NULL
derived	NULL
previously	NULL
.	NULL
'	NULL

''	NULL
``	NULL
*	NULL
Murine	NULL
Ch/b	NULL
complementary	NULL
DNAs	NULL
(	NULL
cDNAs	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
a	NULL
murine	NULL
stem	NULL
cell	NULL
viral	NULL
vector	NULL
harboring	NULL
a	NULL
puromycin-N-acetyltransferase	NULL
gene	NULL
(	NULL
MSCVpac	NULL
)	NULL
``	NULL
*	NULL
(	NULL
subcloning	NULL
details	NULL
will	NULL
be	NULL
provided	NULL
on	NULL
request	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
packaging	NULL
cell	NULL
line	NULL
and	NULL
transduction	NULL
of	NULL
+/+	NULL
,	NULL
Cbfb	NULL
``	NULL
~	NULL
,	NULL
and	NULL
Cbfb	NULL
'~	NULL
ES	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Pear	NULL
and	NULL
coworkers	NULL
.	NULL
``	NULL

''	NULL
Briefly	NULL
,	NULL
BOSC23	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
the	NULL
CaC	NULL
)	NULL
;	NULL
precipitate	NULL
method	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
mM	NULL
chloroquine	NULL
.	NULL

Retroviral	NULL
supernatants	NULL
(	NULL
3	NULL
mL	NULL
)	NULL
were	NULL
harvested	NULL
48	NULL
hours	NULL
later	NULL
,	NULL
passed	NULL
through	NULL
0.2	NULL
um	NULL
filters	NULL
,	NULL
and	NULL
added	NULL
directly	NULL
to	NULL
subconfluent	NULL
ES	NULL
cell	NULL
cultures	NULL
.	NULL

Polybrene	NULL
(	NULL
4	NULL
g/mL	NULL
;	NULL
hexadimethrine	NULL
bromide	NULL
;	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
added	NULL
and	NULL
cultures	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
3	NULL
hours	NULL
.	NULL

ES	NULL
cell	NULL
culture	NULL
medium	NULL
(	NULL
described	NULL
below	NULL
)	NULL
was	NULL
added	NULL
(	NULL
7	NULL
mL	NULL
)	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
continued	NULL
with	NULL
daily	NULL
changes	NULL
of	NULL
medium	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
,	NULL
transduced	NULL
ES	NULL
cells	NULL
were	NULL
selected	NULL
with	NULL
2	NULL
mg/mL	NULL
puromycin	NULL
and	NULL
maintained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
puromycin	NULL
until	NULL
cells	NULL
in	NULL
control	NULL
cultures	NULL
were	NULL
no	NULL
longer	NULL
alive	NULL
.	NULL

Resistant	NULL
cells	NULL
were	NULL
expanded	NULL
and	NULL
tested	NULL
for	NULL
transgene	NULL
expression	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Thereaf-	NULL
CBFB	NULL
AND	NULL
CBFB-SMMHC	NULL
IN	NULL
DEFINITIVE	NULL
HEMATOPOIESIS	NULL
-	NULL
2249	NULL
ter	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
puromycin	NULL
,	NULL
but	NULL
no	NULL
significant	NULL
difference	NULL
was	NULL
observed	NULL
in	NULL
either	NULL
protein	NULL
expression	NULL
or	NULL
hematopoietic	NULL
differentiation	NULL
under	NULL
the	NULL
2	NULL
conditions	NULL
.	NULL

Western	NULL
blot	NULL
analyses	NULL
The	NULL
ES	NULL
cell	NULL
lysates	NULL
were	NULL
collected	NULL
in	NULL
IP	NULL
buffer	NULL
(	NULL
150	NULL
mM	NULL
NaCI	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.5	NULL
%	NULL
deoxycholate	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
[	NULL
SDS	NULL
]	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
2.0	NULL
mM	NULL
EGTA	NULL
)	NULL
plus	NULL
protease	NULL
inhibitors	NULL
(	NULL
1	NULL
mg/mL	NULL
pepstatin	NULL
A	NULL
,	NULL
1	NULL
mM	NULL
Pefablock	NULL
,	NULL
2	NULL
mg/mL	NULL
leupeptin	NULL
,	NULL
2	NULL
mg/mL	NULL
aprotinin	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
boiled	NULL
in	NULL
SDS	NULL
loading	NULL
buffer	NULL
,	NULL
resolved	NULL
on	NULL
13	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

CBFB	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
B141.2	NULL
and	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
reagents	NULL
(	NULL
Amersham	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
in	NULL
vitro	NULL
differentiation	NULL
The	NULL
ES	NULL
cells	NULL
were	NULL
maintained	NULL
on	NULL
gelatinized	NULL
flasks	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
with	NULL
15	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Hyclone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
1.5	NULL
X	NULL
10~+	NULL
M	NULL
monothioglycerol	NULL
(	NULL
MTG	NULL
)	NULL
,	NULL
50	NULL
U/mL	NULL
penicillin	NULL
G	NULL
,	NULL
50	NULL
g/mL	NULL
streptomycin	NULL
,	NULL
and	NULL
1000	NULL
U/mL	NULL
leukemia	NULL
inhibitory	NULL
factor	NULL
(	NULL
LIF	NULL
)	NULL
(	NULL
Gibco/BRL	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
hematopoietic	NULL
differentiation	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
.	NULL

Two	NULL
days	NULL
before	NULL
the	NULL
initiation	NULL
of	NULL
differentiation	NULL
,	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
Iscoves	NULL
modified	NULL
Dulbecco	NULL
medium	NULL
(	NULL
IMDM	NULL
)	NULL
containing	NULL
the	NULL
above	NULL
components	NULL
.	NULL

ES	NULL
cells	NULL
were	NULL
trypsinized	NULL
into	NULL
a	NULL
single-cell	NULL
suspension	NULL
and	NULL
plated	NULL
into	NULL
primary	NULL
differentiation	NULL
media	NULL
containing	NULL
1	NULL
%	NULL
methylcellulose	NULL
(	NULL
Fluka	NULL
,	NULL
Ronkonkoma	NULL
,	NULL
NY	NULL
)	NULL
in	NULL
IMDM	NULL
supplemented	NULL
with	NULL
15	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
1-glutamine	NULL
,	NULL
1.5	NULL
X	NULL
10+	NULL
M	NULL
MTG	NULL
,	NULL
50	NULL
pg/mL	NULL
ascorbic	NULL
acid	NULL
,	NULL
200	NULL
g/mL	NULL
iron-saturated	NULL
transferrin	NULL
,	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
(	NULL
20	NULL
ng/mL	NULL
)	NULL
,	NULL
IL-11	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
,	NULL
and	NULL
5	NULL
ng/mL	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
(	NULL
VEGF	NULL
)	NULL
.	NULL

After	NULL
6	NULL
or	NULL
10	NULL
days	NULL
in	NULL
culture	NULL
,	NULL
embryoid	NULL
bodies	NULL
(	NULL
EBs	NULL
)	NULL
were	NULL
disaggregated	NULL
and	NULL
replated	NULL
into	NULL
secondary	NULL
methylcellulose	NULL
cultures	NULL
containing	NULL
10	NULL
%	NULL
plasma-derived	NULL
serum	NULL
(	NULL
Antech	NULL
,	NULL
Tyler	NULL
,	NULL
TX	NULL
)	NULL
,	NULL
5	NULL
%	NULL
protein-free	NULL
hybridoma	NULL
medium	NULL
(	NULL
PFHM2	NULL
,	NULL
Gibco/BRL	NULL
)	NULL
and	NULL
cytokines	NULL
.	NULL

Primitive	NULL
erythroid	NULL
colony	NULL
(	NULL
EryP	NULL
)	NULL
precursors	NULL
were	NULL
enumerated	NULL
by	NULL
replating	NULL
cells	NULL
into	NULL
medium	NULL
containing	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
;	NULL
2	NULL
U/mL	NULL
)	NULL
.	NULL

Epo	NULL
(	NULL
2	NULL
U/mL	NULL
)	NULL
,	NULL
granulo-cyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
;	NULL
2	NULL
ng/mL	NULL
)	NULL
,	NULL
granulocyte-macrophage	NULL
CSF	NULL
(	NULL
GM-CSF	NULL
;	NULL
5	NULL
ng/mL	NULL
)	NULL
,	NULL
macrophage	NULL
CSF	NULL
(	NULL
M-CSF	NULL
;	NULL
5	NULL
ng/mL	NULL
)	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
;	NULL
50	NULL
ng/mL	NULL
)	NULL
,	NULL
IL-1	NULL
(	NULL
5	NULL
ng/mL	NULL
)	NULL
,	NULL
IL-3	NULL
(	NULL
20	NULL
ng/mL	NULL
)	NULL
,	NULL
IL-6	NULL
(	NULL
5	NULL
ng/mL	NULL
)	NULL
,	NULL
IL-11	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
,	NULL
VEGF	NULL
(	NULL
5	NULL
ng/mL	NULL
)	NULL
,	NULL
and	NULL
LIF	NULL
(	NULL
1	NULL
ng/mL	NULL
)	NULL
were	NULL
added	NULL
to	NULL
secondary	NULL
cultures	NULL
to	NULL
support	NULL
differentiation	NULL
of	NULL
EryP	NULL
,	NULL
definitive	NULL
erythroid	NULL
(	NULL
EryD	NULL
)	NULL
,	NULL
myeloid	NULL
,	NULL
and	NULL
mixed	NULL
lineage	NULL
colonies	NULL
.	NULL

All	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
were	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

After	NULL
7	NULL
days	NULL
of	NULL
secondary	NULL
culture	NULL
,	NULL
colonies	NULL
were	NULL
counted	NULL
on	NULL
an	NULL
inverted	NULL
light	NULL
microscope	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
pelleted	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
serum-free	NULL
IMDM	NULL
,	NULL
and	NULL
counted	NULL
before	NULL
the	NULL
preparation	NULL
of	NULL
cytospins	NULL
.	NULL

Slides	NULL
were	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
.	NULL

Differential	NULL
counts	NULL
were	NULL
performed	NULL
by	NULL
2	NULL
individuals	NULL
without	NULL
knowledge	NULL
of	NULL
specimen	NULL
identifications	NULL
.	NULL

Two	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
ES	NULL
cells	NULL
expressing	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
were	NULL
generated	NULL
by	NULL
harvesting	NULL
all	NULL
colonies	NULL
from	NULL
a	NULL
secondary	NULL
differentiation	NULL
plate	NULL
,	NULL
washing	NULL
once	NULL
with	NULL
serum-free	NULL
IMDM	NULL
,	NULL
then	NULL
transferring	NULL
cells	NULL
to	NULL
liquid	NULL
cultures	NULL
of	NULL
RPMI	NULL
1640	NULL
media	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
50	NULL
U/mL	NULL
penicillin	NULL
G	NULL
,	NULL
50	NULL
g/mL	NULL
streptomycin	NULL
,	NULL
10	NULL
ng/mL	NULL
IL-6	NULL
,	NULL
10	NULL
ng/mL	NULL
SCF	NULL
,	NULL
and	NULL
2	NULL
ng/mL	NULL
IL-3	NULL
.	NULL

Globin	NULL
analysis	NULL
Globin	NULL
gene	NULL
expression	NULL
patterns	NULL
of	NULL
colonies	NULL
from	NULL
secondary	NULL
differentiation	NULL
cultures	NULL
were	NULL
analyzed	NULL
by	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
using	NULL
GlassMAX	NULL
RNA	NULL
Microisolation	NULL
Spin	NULL
Cartridges	NULL
(	NULL
Gibco/BRL	NULL
)	NULL
and	NULL
following	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
Qiagen	NULL
OneStep	NULL
RT-PCR	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Valencia	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
used	NULL
for	NULL
both	NULL
reverse	NULL
transcription	NULL
and	NULL
PCR	NULL
amplification	NULL
using	NULL
previously	NULL
published	NULL
primers	NULL
.	NULL

``	NULL
6	NULL
FACS	NULL
analysis	NULL
Cell	NULL
surface	NULL
antigens	NULL
were	NULL
detected	NULL
by	NULL
standard	NULL
immunofluorescence	NULL
assays	NULL
using	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
monoclonal	NULL
antibodies	NULL
to	NULL
CD116	NULL
(	NULL
Mac-1	NULL
)	NULL
,	NULL
CD117	NULL
(	NULL
c-kit	NULL
)	NULL
,	NULL
CD44	NULL
,	NULL
CD4S5R	NULL
(	NULL
B220	NULL
)	NULL
,	NULL
and	NULL
CD31	NULL
(	NULL
Pecam-1	NULL
)	NULL
.	NULL

PE-conjugated	NULL
streptavidin	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
biotinylated	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2250	NULL
-	NULL
MILLER	NULL
etal	NULL
antibody	NULL
to	NULL
CD34	NULL
.	NULL

Appropriate	NULL
isotype	NULL
controls	NULL
were	NULL
included	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

Reagents	NULL
for	NULL
flow	NULL
cytometry	NULL
were	NULL
obtained	NULL
from	NULL
Pharmingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Fluorescence	NULL
was	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Results	NULL
Definitive	NULL
hematopoiesis	NULL
is	NULL
impaired	NULL
in	NULL
Runx1	NULL
and	NULL
CBFB-deficient	NULL
ES	NULL
cells	NULL
Keller	NULL
and	NULL
coworkers	NULL
demonstrated	NULL
that	NULL
ES	NULL
cells	NULL
cultured	NULL
under	NULL
specific	NULL
conditions	NULL
generate	NULL
differentiated	NULL
hematopoietic	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL
``	NULL

''	NULL
Both	NULL
the	NULL
kinetics	NULL
of	NULL
precursor	NULL
development	NULL
and	NULL
the	NULL
responsiveness	NULL
to	NULL
growth	NULL
factors	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
found	NULL
in	NULL
yolk	NULL
sac	NULL
and	NULL
fetal	NULL
liver	NULL
,	NULL
paralleling	NULL
hematopoietic	NULL
development	NULL
that	NULL
occurs	NULL
in	NULL
the	NULL
embryo	NULL
.	NULL

Large	NULL
numbers	NULL
of	NULL
primitive	NULL
erythroid	NULL
precursors	NULL
emerge	NULL
first	NULL
,	NULL
peaking	NULL
at	NULL
day	NULL
7	NULL
of	NULL
primary	NULL
culture	NULL
,	NULL
followed	NULL
by	NULL
precursors	NULL
for	NULL
definitive	NULL
erythroid	NULL
,	NULL
myeloid	NULL
,	NULL
and	NULL
mixed	NULL
erythroid/myeloid	NULL
lineage	NULL
colonies	NULL
(	NULL
peaking	NULL
at	NULL
days	NULL
8-10	NULL
)	NULL
,	NULL
and	NULL
finally	NULL
mast	NULL
cell	NULL
precursors	NULL
(	NULL
day	NULL
10	NULL
)	NULL
.	NULL

We	NULL
cultured	NULL
wild-type	NULL
,	NULL
Runx1'-	NULL
,	NULL
and	NULL
Cbfb	NULL
'-	NULL
ES	NULL
cells	NULL
in	NULL
vitro	NULL
to	NULL
generate	NULL
EBs	NULL
,	NULL
as	NULL
schematically	NULL
illustrated	NULL
in	NULL
Figure	NULL
1	NULL
A	NULL
,	NULL
disaggregated	NULL
the	NULL
EBs	NULL
6	NULL
and	NULL
10	NULL
days	NULL
after	NULL
the	NULL
establishment	NULL
of	NULL
the	NULL
primary	NULL
culture	NULL
,	NULL
and	NULL
replated	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
.	NULL

Cells	NULL
from	NULL
day	NULL
6	NULL
EBs	NULL
were	NULL
cultured	NULL
with	NULL
Epo	NULL
to	NULL
enumerate	NULL
primitive	NULL
erythroid	NULL
precursors	NULL
,	NULL
and	NULL
cells	NULL
from	NULL
day	NULL
10	NULL
EBs	NULL
were	NULL
cultured	NULL
in	NULL
a	NULL
combination	NULL
of	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
that	NULL
support	NULL
the	NULL
Day	NULL
6	NULL
EBs	NULL
Culture	NULL
EBs	NULL
-	NULL
Disaggregate	NULL
,	NULL
Epo	NULL
EryP	NULL
minus	NULL
replate	NULL
in	NULL
LIF	NULL
0°	NULL
methylcellulose	NULL
ES	NULL
Cells	NULL
_	NULL
--	NULL
»	NULL
0	NULL
00	NULL
--	NULL
-10	NULL
0	NULL
O	NULL
20	NULL
Day	NULL
10	NULL
EBs	NULL
EryP	NULL
emmy	NULL
EryD	NULL
Epo	NULL
-	NULL
GM-CSF	NULL
-	NULL
Myeloid	NULL
SCF	NULL
-	NULL
G-CSF	NULL
Mixed	NULL
VEGF	NULL
M-CSF	NULL
IL-4	NULL
_	NULL
IL6	NULL
IL-3	NULL
-	NULL
IL-4	NULL
LIF	NULL
--	NULL
-EryP	NULL
0	NULL
yo	NULL
IJ	NULL
Mysioid	NULL
Mixed	NULL
0	NULL
100	NULL
200	NULL
300	NULL
Colonies	NULL
per	NULL
10°	NULL
Cells	NULL
C	NULL
Secondary	NULL
Differentiation	NULL
of	NULL
Day	NULL
6	NULL
EBs	NULL
ES	NULL
Cells	NULL
+/+	NULL
Runx1-'-	NULL
_	NULL
Cbtb	NULL
~-EryP	NULL
Colonies	NULL
585	NULL
253	NULL
563	NULL
Figure	NULL
1	NULL
.	NULL

Definitive	NULL
hematopoiesis	NULL
is	NULL
impaired	NULL
in	NULL
Runx1-	NULL
and	NULL
CBFB-deficient	NULL
ES	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
ES	NULL
cell	NULL
differentiation	NULL
protocol	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Hematopoietic	NULL
progenitor	NULL
development	NULL
in	NULL
EBs	NULL
from	NULL
wild-type	NULL
,	NULL
Runx	NULL
?	NULL

-'~	NULL
,	NULL
and	NULL
Cbfb	NULL
'~	NULL
ES	NULL
cells	NULL
.	NULL

Colony	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
EBs	NULL
generated	NULL
following	NULL
10	NULL
days	NULL
of	NULL
primary	NULL
culture	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
(	NULL
+	NULL
SD	NULL
)	NULL
of	NULL
3	NULL
independent	NULL
plates	NULL
are	NULL
shown	NULL
from	NULL
one	NULL
experiment	NULL
,	NULL
representative	NULL
of	NULL
3	NULL
independent	NULL
experiments	NULL
.	NULL

EryP	NULL
,	NULL
primitive	NULL
erythroid	NULL
colonies	NULL
;	NULL
EryD	NULL
,	NULL
definitive	NULL
erythroid	NULL
colonies	NULL
;	NULL
mixed	NULL
,	NULL
erythroid/myeloid	NULL
colonies	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Control	NULL
cultures	NULL
demonstrating	NULL
that	NULL
day	NULL
6	NULL
EBs	NULL
from	NULL
the	NULL
experiment	NULL
depicted	NULL
in	NULL
panel	NULL
B	NULL
contained	NULL
primitive	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Shown	NULL
are	NULL
total	NULL
colony	NULL
numbers	NULL
per	NULL
10°	NULL
cells	NULL
plated	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
differentiation	NULL
of	NULL
both	NULL
primitive	NULL
and	NULL
definitive	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Day	NULL
6	NULL
EBs	NULL
from	NULL
wild-type	NULL
,	NULL
Runx	NULL
!	NULL

~-	NULL
,	NULL
or	NULL
Chfb-	NULL
``	NULL
-	NULL
ES	NULL
cells	NULL
contained	NULL
large	NULL
numbers	NULL
of	NULL
progenitors	NULL
for	NULL
primitive	NULL
erythroid	NULL
colonies	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Primitive	NULL
erythroid	NULL
colonies	NULL
are	NULL
smaller	NULL
and	NULL
brighter	NULL
red	NULL
and	NULL
composed	NULL
of	NULL
larger	NULL
cells	NULL
than	NULL
definitive	NULL
erythroid	NULL
colonies	NULL
.	NULL

Primitive	NULL
erythroid	NULL
progenitors	NULL
were	NULL
still	NULL
present	NULL
in	NULL
secondary	NULL
cultures	NULL
of	NULL
day	NULL
10	NULL
EBs	NULL
from	NULL
all	NULL
3	NULL
ES	NULL
cell	NULL
lines	NULL
;	NULL
however	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
their	NULL
numbers	NULL
dropped	NULL
markedly	NULL
.	NULL
``	NULL

''	NULL
Only	NULL
day	NULL
10	NULL
EBs	NULL
from	NULL
wild-type	NULL
ES	NULL
cells	NULL
contained	NULL
progenitors	NULL
for	NULL
all	NULL
lineages	NULL
of	NULL
definitive	NULL
colonies	NULL
.	NULL

Day	NULL
10	NULL
EBs	NULL
from	NULL
Runx1~	NULL
``	NULL
~	NULL
ES	NULL
cells	NULL
contained	NULL
only	NULL
primitive	NULL
erythroid	NULL
progenitors	NULL
,	NULL
whereas	NULL
day	NULL
10	NULL
EBs	NULL
from	NULL
Cbfb~	NULL
``	NULL
-	NULL
ES	NULL
cells	NULL
contained	NULL
primitive	NULL
erythroid	NULL
progenitors	NULL
and	NULL
reduced	NULL
numbers	NULL
of	NULL
progenitors	NULL
for	NULL
myeloid	NULL
colonies	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
hematopoietic	NULL
defect	NULL
in	NULL
ES	NULL
cell	NULL
cultures	NULL
mimics	NULL
that	NULL
seen	NULL
in	NULL
Runx1-	NULL
and	NULL
CBFB-deficient	NULL
mice	NULL
,	NULL
in	NULL
that	NULL
definitive	NULL
hematopoiesis	NULL
is	NULL
blocked	NULL
while	NULL
primitive	NULL
erythropoiesis	NULL
is	NULL
spared	NULL
.	NULL

The	NULL
small	NULL
number	NULL
of	NULL
myeloid	NULL
progenitors	NULL
in	NULL
Chfb-	NULL
``	NULL
~	NULL
ES	NULL
cells	NULL
also	NULL
reflects	NULL
data	NULL
obtained	NULL
in	NULL
mice	NULL
,	NULL
where	NULL
we	NULL
observed	NULL
the	NULL
number	NULL
of	NULL
definitive	NULL
hematopoietic	NULL
progenitors	NULL
was	NULL
severely	NULL
,	NULL
but	NULL
not	NULL
completely	NULL
,	NULL
depressed	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
and	NULL
yolk	NULL
sac	NULL
.	NULL

``	NULL
!	NULL

Ectopic	NULL
expression	NULL
of	NULL
Cbfb	NULL
transgenes	NULL
rescues	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
CBFB-deficient	NULL
ES	NULL
cells	NULL
Four	NULL
distinct	NULL
cDNAs	NULL
representing	NULL
alternatively	NULL
spliced	NULL
isoforms	NULL
of	NULL
CBFRB	NULL
have	NULL
been	NULL
isolated	NULL
``	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

Two	NULL
isoforms	NULL
,	NULL
CBFRB	NULL
(	NULL
p22	NULL
)	NULL
and	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
,	NULL
encode	NULL
CBFRB	NULL
proteins	NULL
containing	NULL
187	NULL
and	NULL
182	NULL
amino	NULL
acids	NULL
,	NULL
respectively	NULL
,	NULL
that	NULL
heterodimerize	NULL
efficiently	NULL
with	NULL
CBFa	NULL
subunits	NULL
in	NULL
vitro	NULL
.	NULL
``	NULL

The	NULL
CBFB	NULL
(	NULL
p17.6	NULL
)	NULL
isoform	NULL
lacks	NULL
amino	NULL
acids	NULL
encoded	NULL
in	NULL
exon	NULL
3	NULL
and	NULL
fails	NULL
to	NULL
heterodimerize	NULL
with	NULL
CBFa	NULL
in	NULL
vitro	NULL
.	NULL
``	NULL

CBFB	NULL
(	NULL
p18	NULL
)	NULL
lacks	NULL
amino	NULL
acids	NULL
encoded	NULL
in	NULL
exon	NULL
5	NULL
,	NULL
including	NULL
the	NULL
last	NULL
2	NULL
amino	NULL
acids	NULL
(	NULL
aa	NULL
134-135	NULL
)	NULL
in	NULL
the	NULL
domain	NULL
that	NULL
mediates	NULL
heterodimerization	NULL
with	NULL
CBFa	NULL
«	NULL
.	NULL
``	NULL

''	NULL
The	NULL
Chfb-	NULL
``	NULL
~-	NULL
ES	NULL
cells	NULL
used	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
differentiation	NULL
assay	NULL
contain	NULL
a	NULL
deletion	NULL
in	NULL
exon	NULL
5	NULL
of	NULL
the	NULL
Cbfb	NULL
gene	NULL
.	NULL
``	NULL

RT-PCR	NULL
products	NULL
encoding	NULL
the	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
isoform	NULL
were	NULL
amplified	NULL
from	NULL
embryos	NULL
produced	NULL
from	NULL
the	NULL
same	NULL
Chfb	NULL
'-	NULL
ES	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
a	NULL
noticeable	NULL
decrease	NULL
in	NULL
Chfb	NULL
messenger	NULL
RNA	NULL
level	NULL
was	NULL
observed	NULL
compared	NULL
to	NULL
wild-type	NULL
embryos	NULL
.	NULL
``	NULL

Western	NULL
blotting	NULL
with	NULL
both	NULL
embryos	NULL
and	NULL
ES	NULL
cells	NULL
showed	NULL
that	NULL
levels	NULL
of	NULL
the	NULL
truncated	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
protein	NULL
were	NULL
greatly	NULL
reduced	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
the	NULL
endogenous	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
and	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
proteins	NULL
.	NULL
``	NULL

Heterodimerization	NULL
of	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
with	NULL
CBFa	NULL
on	NULL
DNA	NULL
in	NULL
vitro	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
relatively	NULL
weak	NULL
.	NULL
'	NULL

''	NULL
``	NULL
Specifically	NULL
,	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
dissociates	NULL
more	NULL
readily	NULL
from	NULL
the	NULL
CBFo-DNA	NULL
complex	NULL
than	NULL
does	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
or	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
during	NULL
the	NULL
process	NULL
of	NULL
electrophoresis	NULL
through	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

We	NULL
introduced	NULL
transgenes	NULL
encoding	NULL
all	NULL
4	NULL
CBFRB	NULL
isoforms	NULL
into	NULL
Cbfb~	NULL
``	NULL
-	NULL
ES	NULL
cells	NULL
using	NULL
the	NULL
MSCV	NULL
retroviral	NULL
vector	NULL
.	NULL
``	NULL

Pools	NULL
of	NULL
drug-resistant	NULL
ES	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
screened	NULL
for	NULL
CBFB	NULL
expression	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Ectopically	NULL
expressed	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
and	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
comigrate	NULL
with	NULL
endogenous	NULL
CBFB	NULL
and	NULL
accumulate	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
cells	NULL
.	NULL

Ectopically	NULL
expressed	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
migrates	NULL
faster	NULL
than	NULL
endogenous	NULL
CBFB	NULL
through	NULL
SDS-polyacrylamide	NULL
gels	NULL
.	NULL

The	NULL
steady-state	NULL
level	NULL
of	NULL
ectopically	NULL
expressed	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lanes	NULL
7-8	NULL
)	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
and/or	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
protein	NULL
in	NULL
wild-type	NULL
ES	NULL
cells	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
but	NULL
much	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
endogenous	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
in	NULL
either	NULL
Cbfb*	NULL
``	NULL
*	NULL
or	NULL
Cbfb	NULL
'-	NULL
ES	NULL
cells	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lanes	NULL
1-2	NULL
)	NULL
.	NULL

Ectopically	NULL
expressed	NULL
CBFB	NULL
(	NULL
p17.6	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
endogenous	NULL
CBFB	NULL
(	NULL
p17.6	NULL
)	NULL
,	NULL
were	NULL
not	NULL
detectable	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
and	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
in	NULL
_-ES	NULL
cells	NULL
rescued	NULL
definitive	NULL
hematopoiesis	NULL
,	NULL
indicating	NULL
that	NULL
both	NULL
of	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
CBFB	NULL
AND	NULL
CBFB-SMMHC	NULL
IN	NULL
DEFINITIVE	NULL
HEMATOPOIESIS	NULL
_	NULL
2251	NULL
B	NULL
a-	NULL
@	NULL
=	NULL
&	NULL
@	NULL
§	NULL
foos	NULL
f	NULL
:	NULL
A	NULL
83	NULL
8	NULL
$	NULL
B	NULL
L	NULL
b	NULL
I	NULL
(	NULL
p22	NULL
)	NULL
Transgene	NULL
E	NULL
t	NULL
[	NULL
3	NULL
§	NULL
0	NULL
§	NULL
0	NULL
bo	NULL
he	NULL
2	NULL
2	NULL
:	NULL
I	NULL
I	NULL
I	NULL
Cbib	NULL
Genotype	NULL
t	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
_	NULL
:	NULL
U	NULL
:	NULL
kd	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
w	NULL
62	NULL
-	NULL
«	NULL
carp	NULL
(	NULL
p17.6	NULL
)	NULL
___	NULL
eer	NULL
--	NULL
at	NULL
(	NULL
141	NULL
)	NULL
32	NULL
25	NULL
y	NULL
a	NULL
m	NULL
en	NULL
C	NULL
'~	NULL
%	NULL
*	NULL
.	NULL

vs	NULL
‘	NULL
.	NULL

@	NULL
03	NULL
_	NULL
%	NULL
&	NULL
,	NULL
.or	NULL
.	NULL

2¥_	NULL
15	NULL
%	NULL
:	NULL
ﬂ	NULL
®	NULL
~A	NULL
~*	NULL
«	NULL
¥	NULL
6	NULL
«	NULL
**/	NULL
6	NULL
n.	NULL
``	NULL
c	NULL
B	NULL
2	NULL
te	NULL
.	NULL

°	NULL
'	NULL
:	NULL
C	NULL
``	NULL
.	NULL

ke	NULL
rack	NULL
a=	NULL
'	NULL
.	NULL

CBFA	NULL
(	NULL
141	NULL
gs	NULL
``	NULL
E	NULL
.	NULL

Colony	NULL
D	NULL
+/+	NULL
Chib	NULL
~	NULL
Culture	NULL
Culture	NULL
+1000	NULL
bp	NULL
--	NULL
;	NULL
CBFB	NULL
(	NULL
P22	NULL
)	NULL
--	NULL
;	NULL
CBFB	NULL
(	NULL
P18	NULL
)	NULL
--	NULL
;	NULL
CBFB	NULL
(	NULL
141	NULL
)	NULL
-	NULL
500	NULL
bp	NULL
0	NULL
50	NULL
100	NULL
150	NULL
Colonies	NULL
per	NULL
10°	NULL
Cells	NULL
9	NULL
M	NULL
Figure	NULL
2	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
Cbfb	NULL
transgenes	NULL
rescues	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
CBFB-deficient	NULL
ES	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
showing	NULL
CBFB	NULL
isoforms	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
.	NULL

Also	NULL
shown	NULL
is	NULL
the	NULL
experimentally	NULL
truncated	NULL
CBFB	NULL
(	NULL
141	NULL
)	NULL
protein	NULL
containing	NULL
the	NULL
heterodimerization	NULL
domain	NULL
for	NULL
the	NULL
CBFa	NULL
proteins	NULL
.	NULL

Black	NULL
rectangles	NULL
indicate	NULL
sequences	NULL
within	NULL
the	NULL
heterodimerization	NULL
domain	NULL
.	NULL

Sequences	NULL
C-terminal	NULL
to	NULL
amino	NULL
acid	NULL
165	NULL
in	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
,	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
,	NULL
and	NULL
CBFB	NULL
(	NULL
p17.6	NULL
)	NULL
(	NULL
stippled	NULL
region	NULL
)	NULL
differ	NULL
from	NULL
those	NULL
in	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
CBFB	NULL
proteins	NULL
produced	NULL
by	NULL
ectopic	NULL
expression	NULL
in	NULL
Cbfb	NULL
~	NULL
ES	NULL
cells	NULL
.	NULL

The	NULL
genotype	NULL
of	NULL
the	NULL
ES	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
protein	NULL
produced	NULL
from	NULL
the	NULL
ectopically	NULL
expressed	NULL
Cbib	NULL
transgene	NULL
is	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

Protein	NULL
lysates	NULL
from	NULL
2	NULL
independently	NULL
derived	NULL
cell	NULL
populations	NULL
are	NULL
shown	NULL
.	NULL

Arrow	NULL
points	NULL
to	NULL
the	NULL
endogenous	NULL
CBFB	NULL
protein	NULL
.	NULL

Square	NULL
and	NULL
circle	NULL
indicate	NULL
positions	NULL
of	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
and	NULL
the	NULL
truncated	NULL
CBFB	NULL
(	NULL
141	NULL
)	NULL
proteins	NULL
,	NULL
respectively	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
in	NULL
kilodaltons	NULL
are	NULL
listed	NULL
on	NULL
the	NULL
left	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Left	NULL
panel	NULL
:	NULL
Definitive	NULL
erythroid	NULL
and	NULL
mixed-lineage	NULL
colonies	NULL
generated	NULL
in	NULL
secondary	NULL
cultures	NULL
of	NULL
EBs	NULL
derived	NULL
from	NULL
~	NULL
ES	NULL
cells	NULL
ectopically	NULL
expressing	NULL
the	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
protein	NULL
.	NULL

Closed	NULL
arrow	NULL
indicates	NULL
definitive	NULL
erythroid	NULL
colony	NULL
;	NULL
open	NULL
arrow	NULL
shows	NULL
mixed-lineage	NULL
colony	NULL
.	NULL

Right	NULL
panel	NULL
:	NULL
Cytocentrifuge	NULL
preparation	NULL
of	NULL
definitive	NULL
mixed	NULL
lineage	NULL
colonies	NULL
from	NULL
Cbfb/~	NULL
ES	NULL
cells	NULL
ectopically	NULL
expressing	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
.	NULL

Five	NULL
mixed-lineage	NULL
colonies	NULL
were	NULL
picked	NULL
from	NULL
secondary	NULL
methylcellulose	NULL
cultures	NULL
,	NULL
cytocentrifuged	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
.	NULL

Closed	NULL
arrows	NULL
identify	NULL
myeloid	NULL
cells	NULL
,	NULL
closed	NULL
arrowheads	NULL
show	NULL
nucleated	NULL
erythroid	NULL
cells	NULL
,	NULL
and	NULL
open	NULL
arrowheads	NULL
indicate	NULL
enucleated	NULL
red	NULL
blood	NULL
cells	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Globin	NULL
expression	NULL
analysis	NULL
of	NULL
secondary	NULL
hematopoietic	NULL
colonies	NULL
.	NULL

All	NULL
colonies	NULL
from	NULL
one	NULL
plate	NULL
of	NULL
a	NULL
secondary	NULL
culture	NULL
of	NULL
wild-type	NULL
or	NULL
Cbfb~~	NULL
EBs	NULL
are	NULL
compared	NULL
to	NULL
an	NULL
individual	NULL
definitive	NULL
erythroid	NULL
colony	NULL
picked	NULL
from	NULL
a	NULL
secondary	NULL
culture	NULL
of	NULL
Cbfb~	NULL
ES	NULL
cells	NULL
ectopically	NULL
expressing	NULL
CBFB	NULL
(	NULL
141	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
show	NULL
expression	NULL
of	NULL
BH1	NULL
(	NULL
265	NULL
bp	NULL
)	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
show	NULL
@	NULL
major	NULL
(	NULL
578	NULL
bp	NULL
)	NULL
.	NULL

HPRT	NULL
expression	NULL
(	NULL
249	NULL
bp	NULL
)	NULL
is	NULL
shown	NULL
in	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

A	NULL
100-bp	NULL
molecular	NULL
weight	NULL
ladder	NULL
(	NULL
M	NULL
)	NULL
flanks	NULL
lanes	NULL
1	NULL
to	NULL
9	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Hematopoietic	NULL
progenitor	NULL
development	NULL
in	NULL
EBs	NULL
from	NULL
wild-type	NULL
,	NULL
Cbib	NULL
~	NULL
,	NULL
and	NULL
Cbfb-~	NULL
ES	NULL
cells	NULL
expressing	NULL
Cbib	NULL
transgenes	NULL
.	NULL

Colony	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
EBs	NULL
generated	NULL
from	NULL
10	NULL
days	NULL
of	NULL
primary	NULL
culture	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
of	NULL
2	NULL
or	NULL
3	NULL
independent	NULL
plates	NULL
are	NULL
shown	NULL
from	NULL
one	NULL
experiment	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
4	NULL
independent	NULL
experiments	NULL
.	NULL

Differences	NULL
in	NULL
numbers	NULL
of	NULL
various	NULL
colony	NULL
types	NULL
with	NULL
expression	NULL
of	NULL
different	NULL
transgenes	NULL
were	NULL
not	NULL
statistically	NULL
significant	NULL
.	NULL

these	NULL
CBFB	NULL
isoforms	NULL
are	NULL
functional	NULL
in	NULL
vivo	NULL
(	NULL
Figure	NULL
2C-E	NULL
)	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
also	NULL
restored	NULL
definitive	NULL
hematopoiesis	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
Chb	NULL
'~	NULL
ES	NULL
cells	NULL
may	NULL
produce	NULL
the	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
isoform	NULL
from	NULL
the	NULL
mutated	NULL
Chfb	NULL
locus	NULL
,	NULL
``	NULL
its	NULL
concentration	NULL
in	NULL
Chfb_'~-	NULL
cells	NULL
and	NULL
embryos	NULL
was	NULL
apparently	NULL
insufficient	NULL
for	NULL
in	NULL
vivo	NULL
function	NULL
.	NULL

However	NULL
,	NULL
the	NULL
residual	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
activity	NULL
in	NULL
Cbfb~	NULL
``	NULL
-	NULL
cells	NULL
may	NULL
account	NULL
for	NULL
the	NULL
small	NULL
numbers	NULL
of	NULL
definitive	NULL
hematopoietic	NULL
progenitors	NULL
found	NULL
in	NULL
both	NULL
ES	NULL
cell	NULL
cultures	NULL
and	NULL
mouse	NULL
embryos	NULL
.	NULL
``	NULL

The	NULL
CBFB	NULL
(	NULL
p17.6	NULL
)	NULL
failed	NULL
to	NULL
rescue	NULL
definitive	NULL
hematopoiesis	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
can	NULL
not	NULL
be	NULL
interpreted	NULL
as	NULL
an	NULL
intrinsic	NULL
failure	NULL
of	NULL
CBFB	NULL
(	NULL
p17.6	NULL
)	NULL
to	NULL
rescue	NULL
because	NULL
the	NULL
protein	NULL
was	NULL
not	NULL
detectable	NULL
.	NULL

The	NULL
heterodimerization	NULL
domain	NULL
for	NULL
the	NULL
CBFa	NULL
proteins	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
N-terminal	NULL
135	NULL
amino	NULL
acids	NULL
of	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
and	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
.	NULL
``	NULL

''	NULL
We	NULL
previously	NULL
showed	NULL
that	NULL
an	NULL
amino	NULL
acid	NULL
1	NULL
to	NULL
141	NULL
fragment	NULL
of	NULL
CBFB	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
CBFB	NULL
(	NULL
141	NULL
)	NULL
,	NULL
binds	NULL
to	NULL
a	NULL
Runx1-DNA	NULL
complex	NULL
with	NULL
a	NULL
K	NULL
,	NULL
equivalent	NULL
to	NULL
that	NULL
of	NULL
full-length	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
.	NULL
``	NULL

''	NULL
CBFB	NULL
(	NULL
141	NULL
)	NULL
also	NULL
assumes	NULL
a	NULL
folded	NULL
structure	NULL
indistinguishable	NULL
from	NULL
that	NULL
which	NULL
it	NULL
assumes	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
full-length	NULL
Ectopic	NULL
expression	NULL
of	NULL
CBFB	NULL
(	NULL
141	NULL
)	NULL
restores	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
Chfb	NULL
'-	NULL
ES	NULL
cells	NULL
(	NULL
Figure	NULL
26	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
definitive	NULL
erythroid	NULL
colonies	NULL
was	NULL
confirmed	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
B-globin	NULL
expression	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
.	NULL

Primitive	NULL
erythroid	NULL
cells	NULL
express	NULL
both	NULL
embryonic	NULL
(	NULL
BH1	NULL
)	NULL
and	NULL
adult	NULL
type	NULL
(	NULL
B	NULL
major	NULL
)	NULL
B-globin	NULL
,	NULL
whereas	NULL
definitive	NULL
erythroid	NULL
cells	NULL
express	NULL
only	NULL
the	NULL
B	NULL
major	NULL
gene	NULL
.	NULL

Individual	NULL
definitive	NULL
erythroid	NULL
colonies	NULL
isolated	NULL
from	NULL
secondary	NULL
cultures	NULL
of	NULL
Chfb_'~	NULL
ES	NULL
cells	NULL
expressing	NULL
CBFB	NULL
(	NULL
141	NULL
)	NULL
transcribed	NULL
the	NULL
B	NULL
major	NULL
,	NULL
but	NULL
not	NULL
the	NULL
BHI	NULL
gene	NULL
(	NULL
Figure	NULL
2D	NULL
,	NULL
lanes	NULL
7-8	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
heterodimerization	NULL
domain	NULL
of	NULL
CBFB	NULL
,	NULL
which	NULL
is	NULL
common	NULL
to	NULL
both	NULL
the	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
and	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
isoforms	NULL
,	NULL
is	NULL
sufficient	NULL
for	NULL
CBFB	NULL
function	NULL
in	NULL
hematopoiesis	NULL
in	NULL
this	NULL
assay	NULL
system	NULL
.	NULL

One	NULL
limitation	NULL
of	NULL
the	NULL
rescue	NULL
assay	NULL
is	NULL
that	NULL
numbers	NULL
of	NULL
definitive	NULL
colonies	NULL
produced	NULL
from	NULL
both	NULL
Chfb*	NULL
``	NULL
*	NULL
ES	NULL
cells	NULL
and	NULL
Ch/b-	NULL
'-	NULL
ES	NULL
cells	NULL
expressing	NULL
various	NULL
transgenes	NULL
varied	NULL
from	NULL
5-	NULL
to	NULL
20-fold	NULL
between	NULL
experiments	NULL
,	NULL
making	NULL
quantitative	NULL
comparisons	NULL
of	NULL
the	NULL
ability	NULL
to	NULL
rescue	NULL
difficult	NULL
.	NULL

Although	NULL
the	NULL
rescue	NULL
assay	NULL
is	NULL
not	NULL
quantitative	NULL
,	NULL
under	NULL
no	NULL
circumstances	NULL
did	NULL
we	NULL
detect	NULL
progenitors	NULL
for	NULL
definitive	NULL
erythroid	NULL
or	NULL
mixed	NULL
erythroid/myeloid	NULL
lineage	NULL
colonies	NULL
in	NULL
EBs	NULL
derived	NULL
from	NULL
Cbfb	NULL
'~	NULL
ES	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
scored	NULL
the	NULL
appearance	NULL
of	NULL
definitive	NULL
erythroid	NULL
and	NULL
mixed	NULL
erythroid/myeloid	NULL
lineage	NULL
progenitors	NULL
as	NULL
rescue	NULL
,	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
such	NULL
progenitors	NULL
as	NULL
failure	NULL
to	NULL
rescue	NULL
.	NULL

CBFB-SMMHC	NULL
fails	NULL
to	NULL
rescue	NULL
hematopoiesis	NULL
by	NULL
Cbfb	NULL
--	NULL
ES	NULL
cells	NULL
The	NULL
CBFB-SMMHC	NULL
fusion	NULL
protein	NULL
generated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
was	NULL
shown	NULL
in	NULL
mouse	NULL
``	NULL
knock-in	NULL
``	NULL
studies	NULL
to	NULL
transdominantly	NULL
inhibit	NULL
Runx1-CBFB	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

*	NULL
'	NULL
CBFB-SMMHC	NULL
contains	NULL
the	NULL
N-terminal	NULL
165	NULL
amino	NULL
acids	NULL
of	NULL
CBFB	NULL
,	NULL
including	NULL
the	NULL
intact	NULL
Runx1	NULL
heterodimerization	NULL
domain	NULL
,	NULL
fused	NULL
to	NULL
the	NULL
SMMHC	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2252	NULL
-	NULL
MILLER	NULL
etal	NULL
A	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
+	NULL
CBFB	NULL
(	NULL
187	NULL
)	NULL
165	NULL
CBFB-SMMHC	NULL
(	NULL
67	NULL
kd	NULL
)	NULL
o	NULL
B	NULL
€	NULL
E	NULL
g	NULL
3	NULL
5	NULL
s	NULL
&	NULL
7	NULL
a	NULL
=	NULL
r	NULL
T	NULL
®	NULL
Fs	NULL
Transgene	NULL
2	NULL
a	NULL
.	NULL

§	NULL
§	NULL
§	NULL
&	NULL
S	NULL
A	NULL
o_	NULL
o	NULL
a	NULL
Cbtb	NULL
Genotype	NULL
|	NULL
$	NULL
-	NULL
4	NULL
+	NULL
£0	NULL
G4	NULL
Koo	NULL
¢	NULL
8	NULL
kd	NULL
.	NULL

*	NULL
%	NULL
-	NULL
C	NULL
62-	NULL
i	NULL
«	NULL
aam	NULL
«	NULL
«	NULL
«	NULL
«	NULL
mus	NULL
*	NULL
wells	NULL
,	NULL
~-	NULL
ules	NULL
~	NULL
ves	NULL
mses	NULL
ace	NULL
ar	NULL
-	NULL
wn	NULL
tt	NULL
>	NULL
as	NULL
+/+	NULL
a+	NULL
;	NULL
CBFB-SMMHC	NULL
ot	NULL
#	NULL
4	NULL
:	NULL
CBF3-SMMHC	NULL
-/-	NULL
;	NULL
0	NULL
100	NULL
200	NULL
300	NULL
Colonies	NULL
per	NULL
10°	NULL
Cells	NULL
Figure	NULL
3	NULL
.	NULL

Ectopically	NULL
expressed	NULL
CBFB-SMMHC	NULL
does	NULL
not	NULL
inhibit	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
wild-type	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
protein	NULL
and	NULL
one	NULL
of	NULL
the	NULL
CBFB-SMMHC	NULL
proteins	NULL
generated	NULL
by	NULL
the	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
documenting	NULL
ectopic	NULL
expression	NULL
of	NULL
the	NULL
67-kd	NULL
CBFB-SMMHC	NULL
protein	NULL
in	NULL
Cbfb*	NULL
``	NULL
*	NULL
,	NULL
Cbfb*	NULL
``	NULL
~	NULL
,	NULL
and	NULL
Cbfb	NULL
/-	NULL
ES	NULL
cells	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
71-kd	NULL
CBFB-SMMHC	NULL
protein	NULL
in	NULL
cells	NULL
heterozygous	NULL
for	NULL
a	NULL
``	NULL
knocked-in	NULL
``	NULL
allele	NULL
.	NULL

*	NULL
'	NULL
Open	NULL
arrow	NULL
indicates	NULL
the	NULL
endogenous	NULL
CBFB	NULL
proteins	NULL
;	NULL
closed	NULL
arrows	NULL
indicate	NULL
the	NULL
ectopically	NULL
expressed	NULL
CBFB-SMMHC	NULL
proteins	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Hematopoietic	NULL
progenitor	NULL
development	NULL
in	NULL
EBs	NULL
derived	NULL
from	NULL
ES	NULL
cells	NULL
expressing	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
.	NULL

The	NULL
Cbib	NULL
genotype	NULL
of	NULL
the	NULL
ES	NULL
cell	NULL
is	NULL
indicated	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
protein	NULL
expressed	NULL
from	NULL
the	NULL
transgene	NULL
.	NULL

Colony	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
EBs	NULL
generated	NULL
from	NULL
10	NULL
days	NULL
of	NULL
primary	NULL
culture	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
(	NULL
+	NULL
SD	NULL
)	NULL
of	NULL
total	NULL
colony	NULL
numbers	NULL
in	NULL
3	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
colony	NULL
numbers	NULL
in	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
the	NULL
transgene	NULL
were	NULL
not	NULL
statistically	NULL
significant	NULL
.	NULL

tail	NULL
.	NULL
``	NULL

We	NULL
ectopically	NULL
expressed	NULL
a	NULL
67-kd	NULL
isoform	NULL
of	NULL
CBFB-SMMHC	NULL
in	NULL
Chfb*	NULL
'	NULL
``	NULL
*	NULL
,	NULL
Cbfb*	NULL
``	NULL
~	NULL
,	NULL
and	NULL
Chfb_'-	NULL
ES	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
confirms	NULL
expression	NULL
of	NULL
CBFB-SMMHC	NULL
in	NULL
all	NULL
3	NULL
cell	NULL
lines	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

The	NULL
CBFB-SMMHC	NULL
protein	NULL
concentration	NULL
appears	NULL
to	NULL
be	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
endogenous	NULL
CBFR	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
but	NULL
the	NULL
transfer	NULL
efficiency	NULL
of	NULL
the	NULL
2	NULL
proteins	NULL
may	NULL
differ	NULL
,	NULL
making	NULL
direct	NULL
comparisons	NULL
difficult	NULL
.	NULL

Progenitors	NULL
for	NULL
definitive	NULL
erythroid	NULL
and	NULL
mixed	NULL
lineage	NULL
colonies	NULL
were	NULL
present	NULL
in	NULL
EBs	NULL
derived	NULL
from	NULL
Chfb*	NULL
``	NULL
*	NULL
and	NULL
Chfb*	NULL
``	NULL
~	NULL
ES	NULL
cells	NULL
expressing	NULL
the	NULL
CBFB-SMMHC	NULL
transgene	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
from	NULL
the	NULL
MSCV	NULL
enhancer	NULL
can	NULL
not	NULL
significantly	NULL
impair	NULL
definitive	NULL
hematopoiesis	NULL
in	NULL
this	NULL
assay	NULL
system	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
We	NULL
also	NULL
determined	NULL
whether	NULL
ectopic	NULL
expression	NULL
of	NULL
CBFGB-SMMHC	NULL
fusion	NULL
proteins	NULL
could	NULL
restore	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
Cbfb~	NULL
``	NULL
-	NULL
ES	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
either	NULL
the	NULL
67-kd	NULL
(	NULL
Figures	NULL
3C	NULL
and	NULL
4C	NULL
)	NULL
or	NULL
the	NULL
71-kd	NULL
(	NULL
Figure	NULL
4C	NULL
)	NULL
isoforms	NULL
of	NULL
CBFB-SMMHC	NULL
failed	NULL
to	NULL
rescue	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL

This	NULL
indicates	NULL
either	NULL
that	NULL
expression	NULL
levels	NULL
of	NULL
these	NULL
proteins	NULL
were	NULL
insufficient	NULL
to	NULL
restore	NULL
CBFB	NULL
function	NULL
,	NULL
or	NULL
that	NULL
the	NULL
CBFB-SMMHC	NULL
proteins	NULL
are	NULL
intrinsically	NULL
defective	NULL
in	NULL
providing	NULL
CBFB	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
lacking	NULL
the	NULL
C-terminal	NULL
317	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
SMMHC	NULL
tail	NULL
region	NULL
,	NULL
CBFRB-SMMHC4¢3	NULL
!	NULL
``	NULL

(	NULL
Figure	NULL
4A	NULL
)	NULL
,	NULL
when	NULL
ectopically	NULL
expressed	NULL
at	NULL
approximately	NULL
equivalent	NULL
levels	NULL
as	NULL
the	NULL
full-length	NULL
CBFB-SMMHC	NULL
proteins	NULL
(	NULL
Figure	NULL
4B	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
,	NULL
rescued	NULL
definitive	NULL
hematopoiesis	NULL
of	NULL
Chfb	NULL
'-	NULL
ES	NULL
cells	NULL
(	NULL
Figure	NULL
4C	NULL
)	NULL
.	NULL

CBFB-SMMHC43	NULL
``	NULL
lacks	NULL
SMMHC	NULL
sequences	NULL
that	NULL
enable	NULL
it	NULL
to	NULL
associate	NULL
with	NULL
and	NULL
sequester	NULL
CBFa	NULL
subunits	NULL
on	NULL
cytoplasmic	NULL
actin	NULL
filaments	NULL
.	NULL
``	NULL

We	NULL
therefore	NULL
conclude	NULL
that	NULL
the	NULL
full-length	NULL
CBFB-SMMHC	NULL
protein	NULL
is	NULL
intrinsically	NULL
deficient	NULL
in	NULL
its	NULL
A	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p22	NULL
)	NULL
165	NULL
-__	NULL
m	NULL
(	NULL
71	NULL
kd	NULL
)	NULL
165	NULL
CBFj-SMMHC	NULL
(	NULL
67	NULL
kd	NULL
)	NULL
(	NULL
1-165	NULL
)	NULL
15s	NULL
aC317	NULL
B	NULL
2	NULL
2	NULL
m	NULL
50	NULL
&	NULL
8	NULL
o	NULL
o	NULL
4	NULL
I	NULL
o	NULL
so	NULL
&	NULL
e	NULL
30	NULL
f	NULL
g	NULL
$	NULL
;	NULL
®	NULL
7	NULL
a	NULL
&	NULL
©	NULL
Transgene	NULL
R	NULL
a	NULL
&	NULL
>	NULL
4	NULL
te	NULL
A	NULL
Ue	NULL
i	NULL
ic	NULL
t	NULL
&	NULL
G	NULL
G	NULL
a	NULL
Chtb	NULL
Genoty	NULL
3	NULL
T	NULL
3	NULL
I	NULL
q	NULL
4	NULL
enotype	NULL
«	NULL
4	NULL
a	NULL
l	NULL
4	NULL
4	NULL
kd	NULL
T	NULL
€	NULL
JI	NULL
‘	NULL
7T	NULL
i	NULL
T	NULL
83-	NULL
See	NULL
Suse	NULL
ails	NULL
wam	NULL
__	NULL
6	NULL
«	NULL
62-	NULL
T.-	NULL
*	NULL
«	NULL
E	NULL
g	NULL
«	NULL
aas	NULL
«	NULL
ims	NULL
47	NULL
-	NULL
s	NULL
p-	NULL
se	NULL
«	NULL
eme	NULL
.	NULL

+-32	NULL
-	NULL
dh	NULL
cam	NULL
ans	NULL
qaim	NULL
*	NULL
#	NULL
*	NULL
t	NULL
-=	NULL
«	NULL
iis	NULL
25	NULL
-	NULL
.	NULL

«	NULL
°	NULL
#	NULL
-	NULL
L	NULL
_	NULL
d	NULL
.	NULL

165-	NULL
wt	NULL
ae	NULL
i	NULL
*~	NULL
<	NULL
&	NULL
z-	NULL
2	NULL
&	NULL
1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
C	NULL
Transgene	NULL
*=	NULL
uus	NULL
EryP	NULL
0	NULL
Ey	NULL
FZC	NULL
B	NULL
Mycioid	NULL
(	NULL
71	NULL
kd	NULL
)	NULL
esses	NULL
Mixed	NULL
:	NULL
CBFf-SMMHC	NULL
(	NULL
67	NULL
kd	NULL
)	NULL
CBFp	NULL
(	NULL
p22	NULL
)	NULL
ig	NULL
carp	NULL
(	NULL
1-155	NULL
)	NULL
ME	NULL
rerere	NULL
(	NULL
acs17	NULL
)	NULL
0	NULL
200	NULL
400	NULL
600	NULL
800	NULL
Colonies	NULL
per	NULL
10°	NULL
Cells	NULL
Figure	NULL
4	NULL
.	NULL

Sequences	NULL
in	NULL
the	NULL
SMMHC	NULL
portion	NULL
of	NULL
CBFB-SMMHC	NULL
inhibit	NULL
CBFRB	NULL
function	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
human	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
,	NULL
the	NULL
CBFB-SMMHC	NULL
proteins	NULL
generated	NULL
by	NULL
the	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
experimentally	NULL
truncated	NULL
derivatives	NULL
of	NULL
human	NULL
CBFB	NULL
and	NULL
CBFB-SMMHC	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
documenting	NULL
expression	NULL
of	NULL
the	NULL
proteins	NULL
illustrated	NULL
in	NULL
panel	NULL
A	NULL
in	NULL
Cbfb-~	NULL
ES	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Colony	NULL
formation	NULL
by	NULL
Cbfb-~	NULL
ES	NULL
cells	NULL
expressing	NULL
the	NULL
transgenes	NULL
shown	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B.	NULL
Assays	NULL
were	NULL
performed	NULL
with	NULL
EBs	NULL
following	NULL
10	NULL
days	NULL
of	NULL
primary	NULL
differentiation	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
from	NULL
2	NULL
or	NULL
3	NULL
independent	NULL
plates	NULL
are	NULL
shown	NULL
from	NULL
one	NULL
experiment	NULL
,	NULL
representative	NULL
of	NULL
3	NULL
independent	NULL
experiments	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
ability	NULL
to	NULL
restore	NULL
CBFB	NULL
function	NULL
in	NULL
Chfb_	NULL
``	NULL
~	NULL
ES	NULL
cells	NULL
,	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
SMMHC	NULL
sequences	NULL
.	NULL

CBFB-SMMHC	NULL
impairs	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
To	NULL
address	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
concentration	NULL
of	NULL
ectopically	NULL
expressed	NULL
CBFB-SMMHC	NULL
was	NULL
not	NULL
adequate	NULL
to	NULL
overcome	NULL
endogenous	NULL
wild-type	NULL
CBFB	NULL
function	NULL
in	NULL
this	NULL
assay	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
hematopoietic	NULL
potential	NULL
of	NULL
ES	NULL
cells	NULL
heterozygous	NULL
for	NULL
a	NULL
ChJb-MYH11	NULL
``	NULL
knock-in	NULL
``	NULL
allele	NULL
.	NULL

This	NULL
allele	NULL
was	NULL
generated	NULL
by	NULL
replacing	NULL
a	NULL
portion	NULL
of	NULL
exon	NULL
5	NULL
from	NULL
the	NULL
mouse	NULL
Chfb	NULL
gene	NULL
with	NULL
exon	NULL
5	NULL
sequences	NULL
from	NULL
the	NULL
human	NULL
CBFB	NULL
gene	NULL
,	NULL
fused	NULL
to	NULL
MYH11	NULL
sequences	NULL
.	NULL
``	NULL

Both	NULL
the	NULL
normal	NULL
CBFB	NULL
proteins	NULL
and	NULL
the	NULL
71-kd	NULL
CBFB-SMMHC	NULL
fusion	NULL
protein	NULL
are	NULL
expressed	NULL
from	NULL
the	NULL
endogenous	NULL
Chfb	NULL
promoters	NULL
in	NULL
the	NULL
``	NULL
knock-in	NULL
``	NULL
ES	NULL
cells	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

It	NULL
was	NULL
previously	NULL
demonstrated	NULL
that	NULL
embryos	NULL
heterozygous	NULL
for	NULL
the	NULL
MYB	NULL
!	NULL

allele	NULL
die	NULL
at	NULL
midgestation	NULL
and	NULL
display	NULL
impaired	NULL
definitive	NULL
hematopoiesis	NULL
,	NULL
with	NULL
severely	NULL
depressed	NULL
numbers	NULL
of	NULL
definitive	NULL
hematopoietic	NULL
progenitors	NULL
in	NULL
fetal	NULL
livers	NULL
and	NULL
yolk	NULL
sacs	NULL
.	NULL
``	NULL

The	NULL
ES	NULL
cells	NULL
heterozygous	NULL
for	NULL
the	NULL
Chfb	NULL
***	NULL
``	NULL
!	NULL

allele	NULL
produced	NULL
significantly	NULL
more	NULL
definitive	NULL
hematopoietic	NULL
progenitors	NULL
than	NULL
either	NULL
Cbfb-	NULL
``	NULL
-or	NULL
RunxI-	NULL
``	NULL
-	NULL
ES	NULL
cells	NULL
in	NULL
vitro	NULL
(	NULL
Figures	NULL
5A	NULL
and	NULL
1B	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
definitive	NULL
progenitors	NULL
generated	NULL
by	NULL
E5	NULL
cells	NULL
was	NULL
in	NULL
fact	NULL
only	NULL
modestly	NULL
reduced	NULL
,	NULL
ranging	NULL
from	NULL
0-	NULL
to	NULL
10-fold	NULL
in	NULL
independent	NULL
experiments	NULL
,	NULL
relative	NULL
to	NULL
progenitor	NULL
numbers	NULL
from	NULL
wild-type	NULL
ES	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
same	NULL
ratio	NULL
of	NULL
CBFB-SMMHC	NULL
to	NULL
CBFR	NULL
sufficient	NULL
to	NULL
cause	NULL
embryonic	NULL
lethality	NULL
in	NULL
mice	NULL
is	NULL
insufficient	NULL
to	NULL
completely	NULL
block	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
ES	NULL
cells	NULL
cultured	NULL
in	NULL
vitro	NULL
.	NULL

Although	NULL
the	NULL
absolute	NULL
numbers	NULL
of	NULL
definitive	NULL
colonies	NULL
produced	NULL
by	NULL
the	NULL
ES	NULL
cells	NULL
were	NULL
only	NULL
modestly	NULL
reduced	NULL
compared	NULL
to	NULL
wild-type	NULL
ES	NULL
cells	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
CBFB-SMMHC	NULL
fusion	NULL
protein	NULL
preferentially	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
myeloid	NULL
colonies	NULL
,	NULL
relative	NULL
to	NULL
primitive	NULL
and/or	NULL
definitive	NULL
erythroid	NULL
colonies	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

Cytospins	NULL
of	NULL
secondary	NULL
cultures	NULL
from	NULL
wild-type	NULL
and	NULL
BS	NULL
cells	NULL
revealed	NULL
significantly	NULL
different	NULL
ratios	NULL
of	NULL
individual	NULL
cell	NULL
types	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
cells	NULL
derived	NULL
from	NULL
wild-type	NULL
ES	NULL
cells	NULL
were	NULL
macrophage-like	NULL
with	NULL
prominent	NULL
foamy	NULL
cytoplasm	NULL
.	NULL

Hematopoietic	NULL
cells	NULL
from	NULL
colonies	NULL
derived	NULL
from	NULL
BS	NULL
cells	NULL
were	NULL
more	NULL
heterogeneous	NULL
.	NULL

Many	NULL
more	NULL
cells	NULL
showed	NULL
evidence	NULL
of	NULL
erythroid	NULL
differentiation	NULL
,	NULL
including	NULL
multinucleate	NULL
forms	NULL
.	NULL

There	NULL
was	NULL
some	NULL
maturation	NULL
to	NULL
macrophage-like	NULL
cells	NULL
.	NULL

Occasional	NULL
cells	NULL
were	NULL
granulated	NULL
,	NULL
suggesting	NULL
mast	NULL
cell	NULL
differentiation	NULL
.	NULL

Many	NULL
precursor	NULL
cells	NULL
with	NULL
higher	NULL
nuclear	NULL
cytoplasmic	NULL
ratios	NULL
and	NULL
nucleoli	NULL
were	NULL
also	NULL
present	NULL
.	NULL

Enumeration	NULL
of	NULL
these	NULL
various	NULL
cell	NULL
types	NULL
indicated	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
mature	NULL
myeloid	NULL
cells	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
erythroid	NULL
and	NULL
blast-like	NULL
cells	NULL
in	NULL
cultures	NULL
derived	NULL
from	NULL
ES	NULL
cells	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

Because	NULL
we	NULL
observed	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
primitive	NULL
erythroid	NULL
colonies	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
the	NULL
overall	NULL
increase	NULL
in	NULL
erythroid	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
primitive	NULL
erythroid	NULL
cells	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
CbfbC®	NULL
``	NULL
>	NULL
*Y	NULL
``	NULL
!	NULL

``	NULL
+	NULL
cell	NULL
line	NULL
Hematopoietic	NULL
colonies	NULL
from	NULL
secondary	NULL
cultures	NULL
of	NULL
Chfb*'*	NULL
,	NULL
Cbfb_'~-	NULL
,	NULL
and	NULL
ChfbCOPMYHW/+	NULL
BES	NULL
cells	NULL
were	NULL
recovered	NULL
from	NULL
methylcellulose	NULL
cultures	NULL
,	NULL
disaggregated	NULL
,	NULL
and	NULL
grown	NULL
in	NULL
liquid	NULL
cultures	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
SCF	NULL
,	NULL
following	NULL
the	NULL
procedure	NULL
described	NULL
by	NULL
Okuda	NULL
and	NULL
coworkers	NULL
.	NULL
``	NULL

Two	NULL
cell	NULL
lines	NULL
were	NULL
independently	NULL
derived	NULL
from	NULL
the	NULL
ES	NULL
cells	NULL
.	NULL

After	NULL
approximately	NULL
25	NULL
days	NULL
in	NULL
culture	NULL
,	NULL
one	NULL
cell	NULL
line	NULL
(	NULL
KI-1	NULL
)	NULL
began	NULL
to	NULL
expand	NULL
,	NULL
reaching	NULL
logarithmic	NULL
growth	NULL
after	NULL
35	NULL
days	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

The	NULL
second	NULL
line	NULL
(	NULL
KI-2	NULL
)	NULL
began	NULL
to	NULL
actively	NULL
proliferate	NULL
after	NULL
approximately	NULL
75	NULL
CBFB	NULL
AND	NULL
CBFB-SMMHC	NULL
IN	NULL
DEFINITIVE	NULL
HEMATOPOIESIS	NULL
_	NULL
2253	NULL
Chtb	NULL
**	NULL
Chr	NULL
»	NULL
Chm	NULL
myn	NULL
Colonies	NULL
per	NULL
10°	NULL
Cells	NULL
B	NULL
EryP	NULL
EryD	NULL
Myeloid	NULL
Mix	NULL
Cbtb	NULL
**	NULL
5.9	NULL
(	NULL
6.7	NULL
)	NULL
8.4	NULL
(	NULL
3.9	NULL
)	NULL
65.5	NULL
(	NULL
12.8	NULL
)	NULL
20.1	NULL
(	NULL
13.7	NULL
)	NULL
Chip	NULL
***	NULL
44.6	NULL
(	NULL
10.2	NULL
)	NULL
11.7	NULL
(	NULL
6.7	NULL
)	NULL
19.1	NULL
(	NULL
6.9	NULL
)	NULL
24.6	NULL
(	NULL
9.2	NULL
)	NULL
C	NULL
Cbtb	NULL
**	NULL
Ch	NULL
gp	NULL
Chote	NULL
``	NULL
a	NULL
pe	NULL
Nps	NULL
.	NULL

¥	NULL
2	NULL
%	NULL
,	NULL
a	NULL
``	NULL
%	NULL
2	NULL
.	NULL

%	NULL
'm	NULL
%	NULL
A	NULL
def	NULL
28	NULL
``	NULL
4+	NULL
£	NULL
as	NULL
0	NULL
o	NULL
M	NULL
ers	NULL
-	NULL
$	NULL
t	NULL
tq	NULL
f	NULL
``	NULL
``	NULL
a	NULL
¢	NULL
t	NULL
.	NULL

6a	NULL
Cane	NULL
``	NULL
rs-	NULL
``	NULL
f.	NULL
“	NULL
(	NULL
32	NULL
W	NULL
*	NULL
44+	NULL
.	NULL

I	NULL
wep	NULL
ws	NULL
``	NULL
Fou	NULL
on	NULL
ns	NULL
%	NULL
h	NULL
Ye	NULL
``	NULL
4°	NULL
``	NULL
.+	NULL
mil	NULL
gie	NULL
+s	NULL
i	NULL
#	NULL
4	NULL
ee	NULL
-	NULL
x	NULL
``	NULL
,	NULL
ge	NULL
t*	NULL
:	NULL
m	NULL
15.1	NULL
®	NULL
*	NULL
%	NULL
#	NULL
an	NULL
fe	NULL
ts	NULL
.	NULL

,	NULL
Erythroid	NULL
_	NULL
8.6	NULL
(	NULL
3	NULL
)	NULL
Erythroid	NULL
-	NULL
32.8	NULL
(	NULL
8	NULL
)	NULL
Myeloid	NULL
_	NULL
72.2	NULL
(	NULL
1.3	NULL
)	NULL
Myeloid	NULL
_	NULL
22.5	NULL
(	NULL
3.1	NULL
)	NULL
Immature	NULL
19.7	NULL
(	NULL
31	NULL
)	NULL
immature	NULL
.	NULL

44.7	NULL
(	NULL
5.1	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

Impaired	NULL
myelopoiesis	NULL
by	NULL
CbfbC®	NULL
``	NULL
*4Y4	NULL
!	NULL

*/+	NULL
ES	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Hematopoietic	NULL
colony	NULL
formation	NULL
by	NULL
ES	NULL
cells	NULL
heterozygous	NULL
for	NULL
a	NULL
``	NULL
knocked-in	NULL
``	NULL
allele	NULL
,	NULL
from	NULL
which	NULL
the	NULL
71-kd	NULL
CBFB-SMMHC	NULL
fusion	NULL
protein	NULL
is	NULL
expressed	NULL
.	NULL

*	NULL
'	NULL
The	NULL
average	NULL
values	NULL
(	NULL
+	NULL
SD	NULL
)	NULL
from	NULL
5	NULL
independent	NULL
experiments	NULL
are	NULL
presented	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Colony	NULL
types	NULL
formed	NULL
from	NULL
Cbfb**	NULL
and	NULL
CbfbO**Y	NULL
``	NULL
**	NULL
ES	NULL
cells	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
percentage	NULL
of	NULL
colonies	NULL
of	NULL
specific	NULL
lineages	NULL
per	NULL
total	NULL
colonies	NULL
,	NULL
followed	NULL
by	NULL
SD	NULL
in	NULL
parentheses	NULL
,	NULL
from	NULL
5	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
differences	NULL
between	NULL
the	NULL
number	NULL
of	NULL
myeloid	NULL
and	NULL
EryP	NULL
colonies	NULL
formed	NULL
by	NULL
the	NULL
Cbfb*	NULL
``	NULL
*	NULL
and	NULL
CbfbC	NULL
``	NULL
*MY	NULL
``	NULL
!	NULL

**	NULL
ES	NULL
cells	NULL
are	NULL
significant	NULL
at	NULL
P	NULL
<	NULL
.005	NULL
by	NULL
Student	NULL
?	NULL

test	NULL
.	NULL

There	NULL
is	NULL
no	NULL
significant	NULL
difference	NULL
between	NULL
the	NULL
number	NULL
of	NULL
EryD	NULL
or	NULL
mixed	NULL
lineage	NULL
colonies	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Cytocentrifuge	NULL
preparations	NULL
of	NULL
hematopoietic	NULL
cells	NULL
derived	NULL
from	NULL
secondary	NULL
cultures	NULL
of	NULL
Cbfb*	NULL
``	NULL
*	NULL
and	NULL
CbfbCbt®MYHH1+	NULL
ES	NULL
cells	NULL
.	NULL

All	NULL
cells	NULL
from	NULL
one	NULL
plate	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
,	NULL
counted	NULL
,	NULL
and	NULL
used	NULL
for	NULL
cytocentrifugation	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
each	NULL
cell	NULL
type	NULL
(	NULL
average	NULL
of	NULL
4	NULL
experiments	NULL
+	NULL
SD	NULL
)	NULL
is	NULL
indicated	NULL
below	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
erythroid	NULL
and	NULL
immature	NULL
cells	NULL
between	NULL
Cbfb*	NULL
``	NULL
*	NULL
and	NULL
CbfbCb®MYH	NULL
!	NULL

!	NULL

/+	NULL
ES	NULL
cells	NULL
is	NULL
significant	NULL
at	NULL
P	NULL
<	NULL
.01	NULL
by	NULL
Student	NULL
ftest	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
myeloid	NULL
cells	NULL
in	NULL
the	NULL
2	NULL
populations	NULL
is	NULL
significant	NULL
at	NULL
P	NULL
<	NULL
.0001.	NULL
days	NULL
in	NULL
culture	NULL
.	NULL

Viable	NULL
cells	NULL
persisted	NULL
in	NULL
liquid	NULL
cultures	NULL
derived	NULL
from	NULL
Cbfb*	NULL
'	NULL
``	NULL
*	NULL
and	NULL
Chfb_'-	NULL
ES	NULL
cells	NULL
for	NULL
up	NULL
to	NULL
70	NULL
days	NULL
but	NULL
active	NULL
proliferation	NULL
was	NULL
never	NULL
observed	NULL
and	NULL
the	NULL
cell	NULL
numbers	NULL
declined	NULL
steadily	NULL
over	NULL
the	NULL
course	NULL
of	NULL
the	NULL
experiment	NULL
.	NULL

Growth	NULL
and	NULL
survival	NULL
of	NULL
all	NULL
cells	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
rapid	NULL
cell	NULL
death	NULL
was	NULL
observed	NULL
in	NULL
their	NULL
absence	NULL
.	NULL

Morphologically	NULL
,	NULL
cells	NULL
derived	NULL
from	NULL
wild-type	NULL
ES	NULL
cells	NULL
displayed	NULL
mast	NULL
cell	NULL
differentiation	NULL
with	NULL
prominent	NULL
purple	NULL
granules	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

Precursor	NULL
cells	NULL
with	NULL
sparse	NULL
granules	NULL
,	NULL
larger	NULL
nuclei	NULL
,	NULL
and	NULL
prominent	NULL
nucleoli	NULL
as	NULL
well	NULL
as	NULL
a	NULL
few	NULL
nongranulated	NULL
precursors	NULL
were	NULL
observed	NULL
.	NULL

The	NULL
KI-1	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
Chb®	NULL
@	NULL
>	NULL
4*4	NULL
!	NULL

/+	NULL
ES	NULL
cells	NULL
showed	NULL
similar	NULL
morphology	NULL
with	NULL
most	NULL
cells	NULL
displaying	NULL
some	NULL
maturation	NULL
toward	NULL
mast	NULL
cells	NULL
,	NULL
but	NULL
occasional	NULL
large	NULL
foamy	NULL
macro-phages	NULL
were	NULL
also	NULL
present	NULL
.	NULL

The	NULL
morphology	NULL
of	NULL
the	NULL
KI-2	NULL
cells	NULL
was	NULL
very	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
either	NULL
the	NULL
KI-1	NULL
cell	NULL
line	NULL
or	NULL
Cbfb*	NULL
``	NULL
*	NULL
cells	NULL
.	NULL

Most	NULL
KI-2	NULL
cells	NULL
were	NULL
fairly	NULL
undifferentiated	NULL
with	NULL
prominent	NULL
nucleoli	NULL
and	NULL
large	NULL
nuclear	NULL
cytoplasmic	NULL
ratios	NULL
.	NULL

Very	NULL
few	NULL
cells	NULL
possessed	NULL
granules	NULL
and	NULL
several	NULL
had	NULL
vacuoles	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

Both	NULL
KI-1	NULL
and	NULL
KI-2	NULL
cells	NULL
continued	NULL
to	NULL
express	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
using	NULL
a	NULL
panel	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
hematopoietic	NULL
cell	NULL
surface	NULL
antigens	NULL
was	NULL
used	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
Chfb®MYH	NULL
!	NULL

W/+	NULL
KJ-1	NULL
and	NULL
KI-2	NULL
cell	NULL
lines	NULL
(	NULL
Figures	NULL
6D	NULL
and	NULL
E	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Both	NULL
cell	NULL
lines	NULL
were	NULL
uniformly	NULL
positive	NULL
for	NULL
high	NULL
levels	NULL
of	NULL
CD44	NULL
.	NULL

CD44	NULL
is	NULL
the	NULL
receptor	NULL
for	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2254	NULL
-	NULL
MILLER	NULL
etal	NULL
A	NULL
BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
Ki-2	NULL
Figure	NULL
6	NULL
.	NULL

Morphology	NULL
and	NULL
cell	NULL
surface	NULL
phenotype	NULL
of	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
secondary	NULL
cultures	NULL
of	NULL
CbfbCbitMY4	NULL
!	NULL

*	NULL
:	NULL
ES	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Growth	NULL
curve	NULL
showing	NULL
expansion	NULL
of	NULL
cells	NULL
derived	NULL
from	NULL
secondary	NULL
cultures	NULL
of	NULL
wild-type	NULL
(	NULL
WT	NULL
,	NULL
@	NULL
)	NULL
and	NULL
CbfbC®*4YH	NULL
!	NULL

*	NULL
#	NULL
+	NULL
ES	NULL
cells	NULL
(	NULL
Kl-1	NULL
,	NULL
C	NULL
,	NULL
and	NULL
Kl-2	NULL
,	NULL
©	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Giemsa	NULL
stains	NULL
of	NULL
cells	NULL
derived	NULL
from	NULL
secondary	NULL
cultures	NULL
of	NULL
Cbfb*	NULL
``	NULL
*	NULL
and	NULL
CbfbCbbMYH	NULL
!	NULL

+	NULL
Eg	NULL
cells	NULL
(	NULL
Kl-1	NULL
,	NULL
Kl-2	NULL
)	NULL
.	NULL

Cytocentrifuge	NULL
preparations	NULL
of	NULL
the	NULL
Cell	NULL
Number	NULL
x	NULL
107	NULL
j	NULL
,	NULL
j	NULL
25	NULL
50	NULL
76	NULL
|	NULL
Days	NULL
in	NULL
Culture	NULL
-	NULL
83	NULL
kad	NULL
00	NULL
-	NULL
62	NULL
kd	NULL
c-Kit	NULL
Pecam-1	NULL
Cbfb*	NULL
``	NULL
*	NULL
and	NULL
Kl-1	NULL
cells	NULL
were	NULL
made	NULL
after	NULL
42	NULL
days	NULL
in	NULL
liquid	NULL
culture	NULL
.	NULL

KIl-2	NULL
preparations	NULL
were	NULL
made	NULL
after	NULL
85	NULL
days	NULL
in	NULL
liquid	NULL
culture	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
documenting	NULL
continued	NULL
expression	NULL
of	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
in	NULL
the	NULL
and	NULL
KI-2	NULL
cell	NULL
lines	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
+/+	NULL
ES	NULL
cells	NULL
;	NULL
2	NULL
,	NULL
CbfbCbibMYH	NULL
!	NULL

+	NULL
ES	NULL
cells	NULL
;	NULL
3	NULL
,	NULL
Kl-1	NULL
cells	NULL
;	NULL
4	NULL
,	NULL
Kl-2	NULL
cells	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

CD34	NULL
(	NULL
D	NULL
)	NULL
Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
surface	NULL
antigen	NULL
expres-	NULL
200	NULL
59.9	NULL
sion	NULL
on	NULL
Kl-1	NULL
cells	NULL
expanded	NULL
in	NULL
liquid	NULL
culture	NULL
.	NULL

Heavy	NULL
black	NULL
line	NULL
represents	NULL
staining	NULL
obtained	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
the	NULL
indicated	NULL
hematopoietic	NULL
antigen	NULL
.	NULL

Lighter	NULL
line	NULL
corresponds	NULL
to	NULL
the	NULL
signal	NULL
obtained	NULL
with	NULL
a	NULL
control	NULL
anti-body	NULL
.	NULL

Number	NULL
in	NULL
upper	NULL
right	NULL
hand	NULL
corner	NULL
indicates	NULL
percentage	NULL
of	NULL
cells	NULL
positive	NULL
for	NULL
surface	NULL
expression	NULL
of	NULL
each	NULL
marker	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
surface	NULL
antigen	NULL
expression	NULL
on	NULL
KI-2	NULL
cells	NULL
.	NULL

a	NULL
a	NULL
10	NULL
Fluorescence	NULL
Intensity	NULL
hyaluronate	NULL
and	NULL
is	NULL
normally	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
on	NULL
B	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Subpopulations	NULL
of	NULL
both	NULL
cell	NULL
lines	NULL
expressed	NULL
similar	NULL
levels	NULL
of	NULL
CD11b	NULL
(	NULL
Mac-1	NULL
)	NULL
,	NULL
a	NULL
marker	NULL
of	NULL
myeloid	NULL
lineage	NULL
commitment	NULL
.	NULL

Approximately	NULL
60	NULL
%	NULL
of	NULL
the	NULL
KI-1	NULL
cells	NULL
and	NULL
30	NULL
%	NULL
of	NULL
the	NULL
KI-2	NULL
cells	NULL
expressed	NULL
CD117	NULL
(	NULL
c-kit	NULL
)	NULL
,	NULL
the	NULL
transmembrane	NULL
tyrosine	NULL
kinase	NULL
receptor	NULL
for	NULL
SCF	NULL
,	NULL
and	NULL
a	NULL
common	NULL
marker	NULL
for	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
CD34	NULL
,	NULL
another	NULL
common	NULL
marker	NULL
of	NULL
progenitor	NULL
cells	NULL
,	NULL
was	NULL
not	NULL
detected	NULL
on	NULL
the	NULL
KI-1	NULL
cells	NULL
but	NULL
37	NULL
%	NULL
of	NULL
the	NULL
KI-2	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
this	NULL
antigen	NULL
.	NULL

CD31	NULL
(	NULL
Pecam-1	NULL
or	NULL
platelet	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecule	NULL
)	NULL
is	NULL
normally	NULL
expressed	NULL
constitutively	NULL
on	NULL
endothelial	NULL
cells	NULL
,	NULL
at	NULL
high	NULL
levels	NULL
on	NULL
definitive	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
,	NULL
and	NULL
only	NULL
weakly	NULL
expressed	NULL
on	NULL
peripheral	NULL
lymphoid	NULL
cells	NULL
and	NULL
platelets	NULL
.	NULL

CD31	NULL
was	NULL
expressed	NULL
at	NULL
very	NULL
high	NULL
levels	NULL
in	NULL
100	NULL
%	NULL
of	NULL
the	NULL
KI-1	NULL
cells	NULL
and	NULL
on	NULL
64	NULL
%	NULL
of	NULL
the	NULL
KI-2	NULL
cells	NULL
.	NULL

Approximately	NULL
5	NULL
%	NULL
of	NULL
both	NULL
lines	NULL
expressed	NULL
CD45R	NULL
(	NULL
B220	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
CD90	NULL
(	NULL
Thy-1	NULL
)	NULL
,	NULL
CD16/	NULL
CD32	NULL
(	NULL
FoeyRII/FeyRIII	NULL
receptor	NULL
)	NULL
,	NULL
or	NULL
CD3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
CBFRB	NULL
is	NULL
the	NULL
non-DNA-binding	NULL
subunit	NULL
of	NULL
the	NULL
CBF	NULL
complexes	NULL
.	NULL

CBFRB	NULL
heterodimerizes	NULL
with	NULL
the	NULL
DNA-binding	NULL
Runt	NULL
domain	NULL
of	NULL
the	NULL
CBFa	NULL
proteins	NULL
,	NULL
and	NULL
increases	NULL
their	NULL
affinity	NULL
for	NULL
DNA	NULL
.	NULL

No	NULL
other	NULL
biochemical	NULL
functions	NULL
of	NULL
the	NULL
CBFRB	NULL
protein	NULL
have	NULL
thus	NULL
far	NULL
been	NULL
demonstrated	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
an	NULL
assay	NULL
for	NULL
CBFRB	NULL
function	NULL
based	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
ectopically	NULL
expressed	NULL
Chfb	NULL
transgenes	NULL
to	NULL
rescue	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
CBFB-deficient	NULL
ES	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

Using	NULL
this	NULL
assay	NULL
,	NULL
we	NULL
show	NULL
that	NULL
2	NULL
CBFB	NULL
isoforms	NULL
previously	NULL
shown	NULL
to	NULL
form	NULL
stable	NULL
heterodimers	NULL
with	NULL
CBFa	NULL
in	NULL
vitro	NULL
,	NULL
CBFB	NULL
(	NULL
p22	NULL
)	NULL
and	NULL
CBFB	NULL
(	NULL
p21.5	NULL
)	NULL
,2	NULL
``	NULL
are	NULL
both	NULL
capable	NULL
of	NULL
providing	NULL
CBFB	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

A	NULL
third	NULL
CBFB	NULL
isoform	NULL
,	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
,	NULL
which	NULL
forms	NULL
an	NULL
unstable	NULL
complex	NULL
with	NULL
CBFa	NULL
and	NULL
DNA	NULL
in	NULL
vitro	NULL
,	NULL
'*	NULL
``	NULL
also	NULL
restores	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
Cbfb_~-	NULL
ES	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
heterodimerization	NULL
domain	NULL
of	NULL
CBFRB	NULL
,	NULL
which	NULL
mediates	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
CBFa	NULL
Runt	NULL
domain	NULL
,	NULL
is	NULL
sufficient	NULL
for	NULL
its	NULL
in	NULL
vivo	NULL
function	NULL
with	NULL
Runx1	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

Kanno	NULL
and	NULL
colleagues	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
CBFB	NULL
heterodimerization	NULL
domain	NULL
can	NULL
support	NULL
transactivation	NULL
by	NULL
Runx1	NULL
,	NULL
using	NULL
a	NULL
transient	NULL
expression	NULL
and	NULL
reporter	NULL
gene	NULL
assay	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

We	NULL
both	NULL
confirm	NULL
and	NULL
extend	NULL
their	NULL
analyses	NULL
by	NULL
demonstrating	NULL
the	NULL
heterodimerization	NULL
domain	NULL
of	NULL
CBFB	NULL
is	NULL
sufficient	NULL
to	NULL
carry	NULL
out	NULL
a	NULL
developmental	NULL
program	NULL
that	NULL
requires	NULL
CBFB	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
to	NULL
rescue	NULL
hematopoiesis	NULL
was	NULL
somewhat	NULL
unexpected	NULL
,	NULL
given	NULL
that	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
is	NULL
synthesized	NULL
from	NULL
the	NULL
endogenous	NULL
mutated	NULL
Chfb	NULL
allele	NULL
in	NULL
Chfb_'-	NULL
ES	NULL
cells	NULL
.	NULL
``	NULL

CBFB	NULL
(	NULL
p18	NULL
)	NULL
lacks	NULL
exon	NULL
S-encoded	NULL
sequences	NULL
,	NULL
including	NULL
2	NULL
amino	NULL
acids	NULL
(	NULL
aa	NULL
134-135	NULL
)	NULL
at	NULL
the	NULL
C-terminus	NULL
of	NULL
the	NULL
heterodimerization	NULL
domain	NULL
defined	NULL
by	NULL
Kagoshima	NULL
and	NULL
coworkers	NULL
.	NULL
``	NULL

Amino	NULL
acids	NULL
134	NULL
to	NULL
135	NULL
reside	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
an	NULL
«	NULL
helix	NULL
spanning	NULL
amino	NULL
acids	NULL
129	NULL
to	NULL
138	NULL
.	NULL
``	NULL

''	NULL
``	NULL
Truncation	NULL
of	NULL
this	NULL
a	NULL
helix	NULL
in	NULL
the	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
isoform	NULL
appears	NULL
to	NULL
destabilize	NULL
the	NULL
heterodimerization	NULL
domain	NULL
to	NULL
some	NULL
extent	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
instability	NULL
of	NULL
ternary	NULL
Runx1-CBFB	NULL
(	NULL
p18	NULL
)	NULL
-DNA	NULL
complexes	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL
``	NULL

However	NULL
,	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
contains	NULL
all	NULL
the	NULL
amino	NULL
acids	NULL
that	NULL
comprise	NULL
the	NULL
interaction	NULL
surface	NULL
for	NULL
the	NULL
CBFa	NULL
Runt	NULL
domain	NULL
,	NULL
®	NULL
``	NULL
and	NULL
when	NULL
present	NULL
at	NULL
sufficiently	NULL
high	NULL
concentrations	NULL
can	NULL
provide	NULL
CBFRB	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
hematopoietic	NULL
block	NULL
resulting	NULL
from	NULL
the	NULL
mutation	NULL
we	NULL
and	NULL
others	NULL
introduced	NULL
into	NULL
the	NULL
Ch/b	NULL
gene	NULL
``	NULL
was	NULL
primarily	NULL
due	NULL
to	NULL
insufficient	NULL
levels	NULL
of	NULL
the	NULL
CBFB	NULL
(	NULL
p18	NULL
)	NULL
protein	NULL
in	NULL
Cbfb_	NULL
``	NULL
-	NULL
ES	NULL
cells	NULL
and	NULL
embryos	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
emergence	NULL
or	NULL
differentiation	NULL
of	NULL
definitive	NULL
hematopoietic	NULL
progenitors	NULL
from	NULL
ES	NULL
cells	NULL
heterozygous	NULL
for	NULL
a	NULL
``	NULL
knocked-in	NULL
``	NULL
allele	NULL
is	NULL
only	NULL
modestly	NULL
impaired	NULL
in	NULL
vitro	NULL
.	NULL

This	NULL
was	NULL
somewhat	NULL
unexpected	NULL
given	NULL
the	NULL
dramatic	NULL
phenotype	NULL
observed	NULL
in	NULL
mice	NULL
heterozygous	NULL
for	NULL
the	NULL
Chfb	NULL
``	NULL
*	NULL
``	NULL
``	NULL
allele	NULL
.	NULL

ChfpCh	NULL
>	NULL
MYH	NULL
!	NULL

``	NULL
+	NULL
mice	NULL
die	NULL
at	NULL
midgestation	NULL
with	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
CNS	NULL
)	NULL
hemorrhaging	NULL
and	NULL
a	NULL
severe	NULL
block	NULL
in	NULL
fetal	NULL
liver	NULL
hematopoiesis.4	NULL
'	NULL
However	NULL
,	NULL
more	NULL
recent	NULL
results	NULL
indicate	NULL
that	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
(	NULL
HSCs	NULL
)	NULL
hemizygous	NULL
for	NULL
the	NULL
Chfb	NULL
*	NULL
``	NULL
!	NULL

allele	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
do	NULL
persist	NULL
in	NULL
adult	NULL
chimeric	NULL
mice	NULL
generated	NULL
with	NULL
Ch	NULL
)	NULL
b	NULL
@	NULL
>	NULL
**	NULL
``	NULL
*+	NULL
E5	NULL
cells	NULL
.	NULL

``	NULL
?	NULL

Chph	NULL
>	NULL
MY4	NULL
!	NULL

/+	NULL
HSCs	NULL
may	NULL
have	NULL
emerged	NULL
in	NULL
chimeric	NULL
mice	NULL
because	NULL
of	NULL
the	NULL
incomplete	NULL
repression	NULL
of	NULL
normal	NULL
Runx1-CBFB	NULL
function	NULL
by	NULL
the	NULL
allele	NULL
.	NULL

The	NULL
Chfb®	NULL
>	NULL
**2	NULL
``	NULL
/+	NULL
HSCs	NULL
were	NULL
found	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
mature	NULL
erythrocytes	NULL
efficiently	NULL
but	NULL
were	NULL
unable	NULL
to	NULL
differentiate	NULL
along	NULL
myeloid	NULL
and	NULL
lymphoid	NULL
lineages	NULL
.	NULL
``	NULL

Transgenic	NULL
mice	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
CBFB-SMMHC	NULL
was	NULL
specifically	NULL
targeted	NULL
to	NULL
myeloid	NULL
cells	NULL
showed	NULL
impairment	NULL
but	NULL
not	NULL
a	NULL
complete	NULL
block	NULL
of	NULL
neutrophil	NULL
differentiation	NULL
.	NULL
``	NULL

The	NULL
in	NULL
vivo	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
ES	NULL
cell	NULL
differentiation	NULL
results	NULL
reported	NULL
here	NULL
and	NULL
suggest	NULL
that	NULL
CBFB-SMMHC	NULL
preferentially	NULL
impairs	NULL
the	NULL
differentiation	NULL
of	NULL
myeloid	NULL
lineage	NULL
cells	NULL
.	NULL

An	NULL
incomplete	NULL
block	NULL
in	NULL
definitive	NULL
hematopoiesis	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
knock-in	NULL
mouse	NULL
models	NULL
,	NULL
in	NULL
which	NULL
cDNAs	NULL
encoding	NULL
the	NULL
AML1-ETO	NULL
fusion	NULL
protein	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
Runxl	NULL
gene	NULL
.	NULL
``	NULL

For	NULL
example	NULL
,	NULL
Yergeau	NULL
and	NULL
associates	NULL
demonstrated	NULL
that	NULL
although	NULL
no	NULL
definitive	NULL
hematopoietic	NULL
colonies	NULL
of	NULL
any	NULL
kind	NULL
could	NULL
be	NULL
cultured	NULL
from	NULL
yolk	NULL
sacs	NULL
derived	NULL
from	NULL
10.5	NULL
days	NULL
post	NULL
coitus	NULL
(	NULL
dpc	NULL
)	NULL
Runx1-deficient	NULL
embryos	NULL
,	NULL
macrophage-like	NULL
colonies	NULL
differentiated	NULL
from	NULL
the	NULL
yolk	NULL
sacs	NULL
of	NULL
embryos	NULL
heterozygous	NULL
for	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
knock-in	NULL
allele	NULL
.	NULL
``	NULL

More	NULL
recently	NULL
and	NULL
dramatically	NULL
,	NULL
Okuda	NULL
and	NULL
coworkers	NULL
reported	NULL
that	NULL
in	NULL
their	NULL
independently	NULL
derived	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
knock-in	NULL
mouse	NULL
strain	NULL
,	NULL
dysplastic	NULL
progenitors	NULL
for	NULL
mixed	NULL
lineage	NULL
colonies	NULL
could	NULL
be	NULL
found	NULL
in	NULL
the	NULL
fetal	NULL
livers	NULL
of	NULL
day	NULL
11.5	NULL
to	NULL
13.5	NULL
embryos	NULL
,	NULL
and	NULL
that	NULL
these	NULL
progenitors	NULL
had	NULL
an	NULL
abnormally	NULL
high	NULL
self-renewal	NULL
capacity	NULL
.	NULL
``	NULL

''	NULL
We	NULL
recently	NULL
found	NULL
that	NULL
the	NULL
hematopoietic	NULL
block	NULL
in	NULL
Runx	NULL
!	NULL

~	NULL
``	NULL
~	NULL
mice	NULL
occurs	NULL
during	NULL
the	NULL
emergence	NULL
of	NULL
definitive	NULL
hematopoietic	NULL
progenitors	NULL
in	NULL
the	NULL
embryo	NULL
(	NULL
North	NULL
and	NULL
colleagues	NULL
,	NULL
unpublished	NULL
results	NULL
,	NULL
2000	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vivo	NULL
data	NULL
from	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
knock-in	NULL
mice	NULL
generated	NULL
by	NULL
Okuda	NULL
and	NULL
coworkers	NULL
suggest	NULL
that	NULL
some	NULL
definitive	NULL
hematopoietic	NULL
progenitors	NULL
escape	NULL
the	NULL
early	NULL
block	NULL
associated	NULL
with	NULL
loss	NULL
of	NULL
Runx1	NULL
function	NULL
and	NULL
emerge	NULL
,	NULL
but	NULL
are	NULL
unable	NULL
to	NULL
complete	NULL
differentiation	NULL
into	NULL
mature	NULL
myeloid	NULL
and	NULL
erythroid	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
impaired	NULL
differentiation	NULL
of	NULL
myeloid	NULL
lineage	NULL
cells	NULL
may	NULL
be	NULL
an	NULL
important	NULL
step	NULL
in	NULL
leukemogenesis	NULL
associated	NULL
with	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
and	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Incomplete	NULL
repression	NULL
of	NULL
wild-type	NULL
Runx1-CBFB	NULL
function	NULL
by	NULL
the	NULL
transdominant	NULL
negative	NULL
AMLI-ETO	NULL
and	NULL
CBFB-MYH11	NULL
alleles	NULL
may	NULL
allow	NULL
for	NULL
the	NULL
expansion	NULL
and	NULL
persistence	NULL
of	NULL
a	NULL
population	NULL
of	NULL
myeloid	NULL
progenitors	NULL
that	NULL
then	NULL
become	NULL
targets	NULL
for	NULL
the	NULL
secondary	NULL
mutations	NULL
required	NULL
for	NULL
leukemic	NULL
transformation	NULL
.	NULL

Continued	NULL
culture	NULL
of	NULL
the	NULL
colonies	NULL
derived	NULL
from	NULL
ES	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
outgrowth	NULL
of	NULL
2	NULL
cell	NULL
lines	NULL
,	NULL
with	NULL
different	NULL
morphologic	NULL
features	NULL
and	NULL
cell	NULL
surface	NULL
phenotypes	NULL
.	NULL

We	NULL
do	NULL
not	NULL
References	NULL
CBFB	NULL
AND	NULL
CBFB-SMMHC	NULL
IN	NULL
DEFINITIVE	NULL
HEMATOPOIESIS	NULL
_	NULL
2255	NULL
understand	NULL
the	NULL
significance	NULL
of	NULL
the	NULL
differences	NULL
between	NULL
the	NULL
2	NULL
cell	NULL
lines	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
whether	NULL
the	NULL
outgrowth	NULL
from	NULL
secondary	NULL
ES	NULL
cell	NULL
cultures	NULL
is	NULL
directly	NULL
caused	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
,	NULL
and	NULL
additional	NULL
experiments	NULL
are	NULL
needed	NULL
to	NULL
more	NULL
completely	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
CBFB-SMMHC	NULL
on	NULL
proliferative	NULL
potential	NULL
.	NULL

However	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
cell	NULL
outgrowth	NULL
suggest	NULL
that	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
by	NULL
itself	NULL
was	NULL
insufficient	NULL
to	NULL
immortalize	NULL
primary	NULL
hematopoietic	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
demonstration	NULL
that	NULL
ChfbCh	NULL
»	NULL
MYH4	NULL
``	NULL
+	NULL
chimeric	NULL
mice	NULL
developed	NULL
leukemias	NULL
only	NULL
at	NULL
a	NULL
low	NULL
frequency	NULL
and	NULL
after	NULL
a	NULL
long	NULL
latent	NULL
period	NULL
.	NULL
``	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
although	NULL
biallelic	NULL
loss	NULL
of	NULL
function	NULL
mutations	NULL
in	NULL
the	NULL
RUNX	NULL
]	NULL
gene	NULL
have	NULL
been	NULL
found	NULL
in	NULL
leukemias	NULL
,	NULL
``	NULL
the	NULL
frequency	NULL
of	NULL
chromosomal	NULL
rearrangements	NULL
of	NULL
and	NULL
CBFB	NULL
in	NULL
leukemias	NULL
is	NULL
greater	NULL
.	NULL

Furthermore	NULL
,	NULL
biallelic	NULL
mutations	NULL
were	NULL
observed	NULL
in	NULL
MO	NULL
leukemias	NULL
,	NULL
which	NULL
are	NULL
minimally	NULL
differentiated	NULL
acute	NULL
myeloid	NULL
leukemias	NULL
,	NULL
whereas	NULL
the	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
and	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
are	NULL
found	NULL
in	NULL
the	NULL
somewhat	NULL
more	NULL
differentiated	NULL
M2	NULL
and	NULL
M4	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
subtypes	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
frequency	NULL
and	NULL
diagnostic	NULL
subtypes	NULL
suggests	NULL
that	NULL
the	NULL
translocations	NULL
and	NULL
loss	NULL
of	NULL
function	NULL
mutations	NULL
involving	NULL
RUNXI	NULL
and	NULL
CBFB	NULL
are	NULL
not	NULL
equivalent	NULL
in	NULL
leukemogenesis	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
CBFB-SMMHC	NULL
and	NULL
AML1-ETO	NULL
to	NULL
completely	NULL
inhibit	NULL
Runx1	NULL
:	NULL
CBFB	NULL
activity	NULL
may	NULL
be	NULL
an	NULL
essential	NULL
feature	NULL
of	NULL
their	NULL
distinct	NULL
leukemogenic	NULL
properties	NULL
.	NULL

We	NULL
were	NULL
also	NULL
able	NULL
to	NULL
document	NULL
an	NULL
intrinsic	NULL
inability	NULL
of	NULL
CBFB-SMMHC	NULL
to	NULL
provide	NULL
CBFB	NULL
function	NULL
in	NULL
vivo	NULL
,	NULL
based	NULL
on	NULL
its	NULL
failure	NULL
to	NULL
restore	NULL
definitive	NULL
hematopoiesis	NULL
by	NULL
Chfb_	NULL
'	NULL
``	NULL
-	NULL
ES	NULL
cells	NULL
.	NULL

This	NULL
observation	NULL
could	NULL
form	NULL
the	NULL
basis	NULL
of	NULL
an	NULL
assay	NULL
for	NULL
evaluating	NULL
the	NULL
biochemical	NULL
properties	NULL
of	NULL
the	NULL
SMMHC	NULL
sequences	NULL
that	NULL
inhibit	NULL
its	NULL
function	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
for	NULL
testing	NULL
candidate	NULL
drugs	NULL
targeted	NULL
against	NULL
the	NULL
CBFB-SMMHC	NULL
protein	NULL
.	NULL

Acknowledgments	NULL
We	NULL
gratefully	NULL
acknowledge	NULL
Stuart	NULL
Orkin	NULL
and	NULL
members	NULL
of	NULL
his	NULL
laboratory	NULL
,	NULL
especially	NULL
Catherine	NULL
Porcher	NULL
,	NULL
for	NULL
their	NULL
technical	NULL
advice	NULL
.	NULL

We	NULL
thank	NULL
Norman	NULL
Levy	NULL
and	NULL
Letha	NULL
Mills	NULL
for	NULL
histopathology	NULL
consultations	NULL
,	NULL
Robert	NULL
Hawley	NULL
for	NULL
providing	NULL
the	NULL
MSCV	NULL
vector	NULL
,	NULL
Neeraj	NULL
Adja	NULL
for	NULL
the	NULL
CBFB-SMMHC	NULL
constructs	NULL
,	NULL
and	NULL
Ken	NULL
Orndorff	NULL
for	NULL
help	NULL
with	NULL
taking	NULL
pictures	NULL
.	NULL

Flow	NULL
cytometry	NULL
was	NULL
done	NULL
at	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
in	NULL
The	NULL
Herbert	NULL
C.	NULL
Englert	NULL
Cell	NULL
Analysis	NULL
Laboratory	NULL
,	NULL
established	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Fannie	NULL
E.	NULL
Rippel	NULL
Foundation	NULL
and	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Core	NULL
Grant	NULL
of	NULL
the	NULL
Norris	NULL
Cotton	NULL
Cancer	NULL
Center	NULL
(	NULL
CA	NULL
23108	NULL
)	NULL
.	NULL

1	NULL
.	NULL

5	NULL
.	NULL

Ogawa	NULL
E	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Kagoshima	NULL
H	NULL
,	NULL
et	NULL
al	NULL
.	NULL

PEBP2/PEAZ	NULL
represents	NULL
a	NULL
new	NULL
family	NULL
of	NULL
transcription	NULL
factor	NULL
homologous	NULL
to	NULL
the	NULL
products	NULL
of	NULL
the	NULL
Drosophila	NULL
runt	NULL
and	NULL
the	NULL
human	NULL
AML1	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1993	NULL
;	NULL
90:6859-6863	NULL
.	NULL

Ogawa	NULL
E	NULL
,	NULL
Inuzuka	NULL
M	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
PEBP28	NULL
,	NULL
the	NULL
heterodimeric	NULL
partner	NULL
of	NULL
a	NULL
novel	NULL
Drosophila	NULL
runt-related	NULL
DNA	NULL
binding	NULL
protein	NULL
PEBP2	NULL
«	NULL
.	NULL

Virol-ogy	NULL
.	NULL

1993	NULL
;	NULL
194:314-331	NULL
.	NULL

Wang	NULL
S	NULL
,	NULL
Wang	NULL
Q	NULL
,	NULL
Crute	NULL
BE	NULL
,	NULL
Melnikova	NULL
IN	NULL
,	NULL
Keller	NULL
SR	NULL
,	NULL
Speck	NULL
NA	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
subunits	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
core-binding	NULL
factor	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1993	NULL
;	NULL
13:3324-3339	NULL
.	NULL

Miyoshi	NULL
H	NULL
,	NULL
Shimizu	NULL
K	NULL
,	NULL
Kozu	NULL
T	NULL
,	NULL
Maseki	NULL
N	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Ohki	NULL
M.	NULL
1	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
breakpoints	NULL
on	NULL
chromosome	NULL
21	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
are	NULL
clustered	NULL
within	NULL
a	NULL
limited	NULL
region	NULL
of	NULL
a	NULL
single	NULL
gene	NULL
,	NULL
AML	NULL
1	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1991	NULL
;	NULL
88:10431-10434	NULL
.	NULL

Bae	NULL
S-C	NULL
,	NULL
Takahashi	NULL
E	NULL
,	NULL
Zhang	NULL
YW	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cloning	NULL
,	NULL
mapping	NULL
and	NULL
expression	NULL
of	NULL
PEBP2	NULL
@	NULL
«	NULL
C	NULL
,	NULL
a	NULL
third	NULL
gene	NULL
encoding	NULL
the	NULL
mammalian	NULL
Runt	NULL
domain	NULL
.	NULL

Gene	NULL
.	NULL

1995	NULL
;	NULL
159:245-248.	NULL
.	NULL

Liu	NULL
P	NULL
,	NULL
Tarle	NULL
SA	NULL
,	NULL
Hajra	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Fusion	NULL
between	NULL
transcription	NULL
factor	NULL
CBFB/PEBP2B	NULL
and	NULL
a	NULL
myosin	NULL
heavy	NULL
chain	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Science	NULL
.	NULL

1993	NULL
;	NULL
261:1041-1044.	NULL
.	NULL

Levanon	NULL
D	NULL
,	NULL
Negreanu	NULL
V	NULL
,	NULL
Bernstein	NULL
Y	NULL
,	NULL
Bar-Am	NULL
I	NULL
,	NULL
Avivi	NULL
L	NULL
,	NULL
Groner	NULL
Y.	NULL
AML1	NULL
,	NULL
AML2	NULL
,	NULL
and	NULL
AML3	NULL
,	NULL
the	NULL
human	NULL
members	NULL
of	NULL
the	NULL
runt	NULL
domain	NULL
gene-family	NULL
:	NULL
cDNA	NULL
structure	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
chromosomal	NULL
localization	NULL
.	NULL

Genomics	NULL
.	NULL

1994	NULL
;	NULL
23:425-432.	NULL
.	NULL

Bae	NULL
SC	NULL
,	NULL
Yamaguchi-lwai	NULL
Y	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Isola-	NULL
tion	NULL
of	NULL
PEBP2	NULL
«	NULL
B	NULL
cDNA	NULL
representing	NULL
the	NULL
mouse	NULL
homolog	NULL
of	NULL
human	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
gene	NULL
,	NULL
AML1	NULL
.	NULL

Oncogene	NULL
.	NULL

1993	NULL
;	NULL
8:809-814.	NULL
.	NULL

Okuda	NULL
T	NULL
,	NULL
van	NULL
Deursen	NULL
J	NULL
,	NULL
Hiebert	NULL
SW	NULL
,	NULL
Grosveld	NULL
G	NULL
,	NULL
Downing	NULL
JR.	NULL
AML1	NULL
,	NULL
the	NULL
target	NULL
of	NULL
multiple	NULL
chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
leukemia	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
normal	NULL
fetal	NULL
liver	NULL
hematopoiesis	NULL
.	NULL

Cell	NULL
.	NULL

1996	NULL
;	NULL
84:321-330	NULL
.	NULL

Wang	NULL
Q	NULL
,	NULL
Stacy	NULL
T	NULL
,	NULL
Binder	NULL
M	NULL
,	NULL
Marin-Padilla	NULL
M	NULL
,	NULL
Sharpe	NULL
AH	NULL
,	NULL
Speck	NULL
NA	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
Cbfa2	NULL
gene	NULL
causes	NULL
necrosis	NULL
and	NULL
hemorrhaging	NULL
in	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
and	NULL
blocks	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1996	NULL
;	NULL
93	NULL
:	NULL
3444-3449.	NULL
.	NULL

Wang	NULL
Q	NULL
,	NULL
Stacy	NULL
T	NULL
,	NULL
Miller	NULL
JD	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
CBFB	NULL
sub	NULL
unit	NULL
is	NULL
essential	NULL
for	NULL
CBFa2	NULL
(	NULL
AML1	NULL
)	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
.	NULL

1996	NULL
;	NULL
87:697-708	NULL
.	NULL

Sasaki	NULL
K	NULL
,	NULL
Yagi	NULL
H	NULL
,	NULL
Bronson	NULL
RT	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Absence	NULL
of	NULL
fetal	NULL
liver	NULL
hematopoiesis	NULL
in	NULL
transcriptional	NULL
co-activator	NULL
,	NULL
core	NULL
binding	NULL
factor	NULL
B	NULL
(	NULL
Cbib	NULL
)	NULL
deficient	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1996	NULL
;	NULL
93:12359-12363	NULL
.	NULL

Niki	NULL
M	NULL
,	NULL
Okada	NULL
H	NULL
,	NULL
Takano	NULL
H	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Hematopoiesis	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
is	NULL
impaired	NULL
by	NULL
targeted	NULL
mutagen-esis	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
non-DNA	NULL
binding	NULL
subunit	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
polyomavirus	NULL
enhancer	NULL
binding	NULL
protein	NULL
2/core	NULL
binding	NULL
factor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1997	NULL
;	NULL
94:5697-5702	NULL
.	NULL

Ingham	NULL
P	NULL
,	NULL
Gergen	NULL
P.	NULL
Interactions	NULL
between	NULL
the	NULL
pair-rule	NULL
genes	NULL
runt	NULL
,	NULL
hairy	NULL
,	NULL
even-skipped	NULL
and	NULL
2256	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

286	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MILLER	NULL
et	NULL
al	NULL
fushi	NULL
tarazu	NULL
and	NULL
the	NULL
establishment	NULL
of	NULL
periodic	NULL
paitern	NULL
in	NULL
the	NULL
Drosophila	NULL
embryo	NULL
.	NULL

Development	NULL
.	NULL

1988	NULL
;	NULL
104	NULL
(	NULL
suppl	NULL
)	NULL
:51-60	NULL
.	NULL

Duffy	NULL
JB	NULL
,	NULL
Gergen	NULL
JP	NULL
.	NULL

The	NULL
Drosophila	NULL
segmentation	NULL
gene	NULL
runt	NULL
acts	NULL
as	NULL
a	NULL
position-specific	NULL
numerator	NULL
element	NULL
necessary	NULL
for	NULL
the	NULL
uniform	NULL
expression	NULL
of	NULL
the	NULL
sex-determining	NULL
gene	NULL
Sex-lethal	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1991	NULL
;	NULL
5:2176-2187	NULL
.	NULL

Duffy	NULL
JB	NULL
,	NULL
Kania	NULL
MA	NULL
,	NULL
Gergen	NULL
JP	NULL
.	NULL

Expression	NULL
and	NULL
function	NULL
of	NULL
the	NULL
Drosophila	NULL
gene	NULL
runt	NULL
in	NULL
early	NULL
stages	NULL
of	NULL
neural	NULL
development	NULL
.	NULL

Development	NULL
.	NULL

1991	NULL
;	NULL
113:1223-1230	NULL
.	NULL

Sanchez	NULL
L	NULL
,	NULL
Nothiger	NULL
R.	NULL
Sex	NULL
determination	NULL
and	NULL
dosage	NULL
compensation	NULL
in	NULL
Drosophila	NULL
melano-gaster	NULL
.	NULL

production	NULL
of	NULL
male	NULL
clones	NULL
in	NULL
XX	NULL
females	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1983	NULL
;	NULL
2:485-491	NULL
.	NULL

Daga	NULL
A	NULL
,	NULL
Karlovich	NULL
CA	NULL
,	NULL
Dumstrei	NULL
K	NULL
,	NULL
Banerjee	NULL
U.	NULL
Patterning	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
Drosophila	NULL
eye	NULL
by	NULL
Loz-enge	NULL
,	NULL
which	NULL
shares	NULL
homologous	NULL
domains	NULL
with	NULL
AML1	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1996	NULL
;	NULL
10:1194-1205	NULL
.	NULL

Stocker	NULL
FR	NULL
,	NULL
Gendre	NULL
N.	NULL
Peripheral	NULL
and	NULL
central	NULL
nervous	NULL
system	NULL
effects	NULL
of	NULL
/z°	NULL
,	NULL
a	NULL
Drosophila	NULL
mutant	NULL
lacking	NULL
basiconic	NULL
antennal	NULL
sensilla	NULL
.	NULL

Dev	NULL
Biol	NULL
.	NULL

1988	NULL
;	NULL
127:12-27	NULL
.	NULL

Rizki	NULL
TM	NULL
,	NULL
Rizki	NULL
RM	NULL
,	NULL
Bellotti	NULL
R.	NULL
Genetics	NULL
of	NULL
a	NULL
Drosophila	NULL
phenoloxidase	NULL
.	NULL

Mol	NULL
Gen	NULL
Genet	NULL
.	NULL

1985	NULL
;	NULL
201:7-13	NULL
.	NULL

Komori	NULL
T	NULL
,	NULL
Yagi	NULL
H	NULL
,	NULL
Nomura	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
Cbfai	NULL
results	NULL
in	NULL
a	NULL
complete	NULL
lack	NULL
of	NULL
bone	NULL
formation	NULL
owing	NULL
to	NULL
maturational	NULL
arrest	NULL
of	NULL
osteoblasts	NULL
.	NULL

Cell	NULL
.	NULL

1997	NULL
;	NULL
89:755-764	NULL
.	NULL

Ofto	NULL
F	NULL
,	NULL
Thornell	NULL
AP	NULL
,	NULL
Crompton	NULL
T	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cbfa1	NULL
,	NULL
a	NULL
candidate	NULL
gene	NULL
for	NULL
Cleidocranial	NULL
dysplasia	NULL
syn-drome	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
osteoblast	NULL
differentiation	NULL
and	NULL
bone	NULL
development	NULL
.	NULL

Cell	NULL
.	NULL

1997	NULL
;	NULL
89:765-772	NULL
.	NULL

Godin	NULL
IE	NULL
,	NULL
Garcia-Porrero	NULL
JA	NULL
,	NULL
Coutinho	NULL
A	NULL
,	NULL
Dieterlen-Lievre	NULL
F	NULL
,	NULL
Marcos	NULL
MAR	NULL
.	NULL

Para-aortic	NULL
splanchnopleura	NULL
from	NULL
early	NULL
mouse	NULL
embryos	NULL
contain	NULL
Bia	NULL
cell	NULL
pro	NULL
genitors	NULL
.	NULL

Nature	NULL
.	NULL

1993	NULL
;	NULL
364:67-70	NULL
.	NULL

Godin	NULL
I	NULL
,	NULL
Dieterlen-Ligvre	NULL
F	NULL
,	NULL
Cumano	NULL
A	NULL
.	NULL

Emergence	NULL
of	NULL
multipotent	NULL
hematopoietic	NULL
cells	NULL
in	NULL
the	NULL
yolk	NULL
sac	NULL
and	NULL
paraaortic	NULL
splanchnopleura	NULL
of	NULL
8.5	NULL
dpc	NULL
mouse	NULL
embryos	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1995	NULL
;	NULL
92:773-777	NULL
.	NULL

Dieterlen-Ligvre	NULL
F	NULL
,	NULL
Martin	NULL
C.	NULL
Diffuse	NULL
intraembry-onic	NULL
hematopoiesis	NULL
in	NULL
normal	NULL
and	NULL
chimeric	NULL
avian	NULL
development	NULL
.	NULL

Dev	NULL
Biol	NULL
.	NULL

1981	NULL
;	NULL
88:180-191	NULL
.	NULL

Miller	NULL
AM	NULL
,	NULL
Medvinsky	NULL
A	NULL
,	NULL
Strouboulis	NULL
J	NULL
,	NULL
Grosveld	NULL
F	NULL
,	NULL
Dzierzak	NULL
E.	NULL
Development	NULL
of	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
activity	NULL
in	NULL
the	NULL
mouse	NULL
embryo	NULL
.	NULL

Immunity	NULL
.	NULL

1994	NULL
;	NULL
1:291-301	NULL
.	NULL

Medvinsky	NULL
AL	NULL
,	NULL
Samoylina	NULL
NL	NULL
,	NULL
Miller	NULL
AM	NULL
,	NULL
Dzierzak	NULL
EA	NULL
.	NULL

An	NULL
early	NULL
pre-liver	NULL
intra-embryonic	NULL
source	NULL
of	NULL
CFU-S	NULL
in	NULL
the	NULL
developing	NULL
mouse	NULL
.	NULL

Nature	NULL
.	NULL

1993	NULL
;	NULL
364:64-66	NULL
.	NULL

Medvinsky	NULL
A	NULL
,	NULL
Dzierzak	NULL
E.	NULL
Definitive	NULL
hematopoiesis	NULL
is	NULL
autonomously	NULL
initiated	NULL
by	NULL
the	NULL
AGM	NULL
region	NULL
.	NULL

Cell	NULL
.	NULL

1996	NULL
;	NULL
86:897-906	NULL
.	NULL

Yoder	NULL
MC	NULL
,	NULL
Hiatt	NULL
K	NULL
,	NULL
Dutt	NULL
P	NULL
,	NULL
Mukherjee	NULL
P	NULL
,	NULL
Bodine	NULL
DM	NULL
,	NULL
Orlic	NULL
D.	NULL
Characterization	NULL
of	NULL
definitive	NULL
lym-phohematopoietic	NULL
stem	NULL
cells	NULL
in	NULL
the	NULL
day	NULL
9	NULL
murine	NULL
yolk	NULL
sac	NULL
.	NULL

Immunity	NULL
.	NULL

1997	NULL
;	NULL
7:335-344	NULL
.	NULL

Moore	NULL
MAS	NULL
,	NULL
Metcalf	NULL
D.	NULL
Ontogeny	NULL
of	NULL
the	NULL
haemo-poietic	NULL
system	NULL
:	NULL
yolk	NULL
sac	NULL
origin	NULL
of	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
colony	NULL
forming	NULL
cells	NULL
in	NULL
the	NULL
developing	NULL
mouse	NULL
embryo	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
.	NULL

1970	NULL
;	NULL
18:279-296	NULL
.	NULL

Ogawa	NULL
M	NULL
,	NULL
Nishikawa	NULL
S	NULL
,	NULL
Ikuta	NULL
K	NULL
,	NULL
et	NULL
al	NULL
.	NULL

B	NULL
cell	NULL
ontogeny	NULL
in	NULL
murine	NULL
embryo	NULL
studied	NULL
by	NULL
a	NULL
culture	NULL
system	NULL
with	NULL
the	NULL
monolayer	NULL
of	NULL
a	NULL
stromal	NULL
cell	NULL
clone	NULL
,	NULL
ST2	NULL
:	NULL
B	NULL
cell	NULL
progenitor	NULL
develops	NULL
first	NULL
in	NULL
the	NULL
em-bryonal	NULL
body	NULL
rather	NULL
than	NULL
in	NULL
the	NULL
yolk	NULL
sac	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1988	NULL
;	NULL
7:1337-1343	NULL
.	NULL

Eren	NULL
R	NULL
,	NULL
Zharhary	NULL
D	NULL
,	NULL
Abel	NULL
L	NULL
,	NULL
Globerson	NULL
A.	NULL
Ontogeny	NULL
of	NULL
T	NULL
cells	NULL
:	NULL
development	NULL
of	NULL
pre-T	NULL
cells	NULL
from	NULL
33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49.	NULL
fetal	NULL
liver	NULL
and	NULL
yolk	NULL
sac	NULL
in	NULL
the	NULL
thymus	NULL
microenvi-ronment	NULL
.	NULL

Cell	NULL
Immunol	NULL
.	NULL

1987	NULL
;	NULL
108:76-84	NULL
.	NULL

Toles	NULL
JF	NULL
,	NULL
Chui	NULL
DH	NULL
,	NULL
Belbeck	NULL
LW	NULL
,	NULL
Starr	NULL
E	NULL
,	NULL
Barker	NULL
JE	NULL
.	NULL

Hematopoietic	NULL
stem	NULL
cells	NULL
in	NULL
murine	NULL
embryonic	NULL
yolk	NULL
sac	NULL
and	NULL
peripheral	NULL
blood	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1989	NULL
;	NULL
86:7456-7459	NULL
.	NULL

Weissman	NULL
IL	NULL
,	NULL
Baird	NULL
S	NULL
,	NULL
Gartner	NULL
RL	NULL
,	NULL
Papaioannou	NULL
VE	NULL
,	NULL
Raschke	NULL
W.	NULL
Normal	NULL
and	NULL
neoplastic	NULL
maturation	NULL
of	NULL
T-lineage	NULL
lymphocytes	NULL
.	NULL

CSH	NULL
Symp	NULL
Quant	NULL
Biol	NULL
.	NULL

1977	NULL
;	NULL
41:9-21.	NULL
de	NULL
Bruijn	NULL
MFTR	NULL
,	NULL
Speck	NULL
NA	NULL
,	NULL
Peeters	NULL
MCE	NULL
,	NULL
Dzierzak	NULL
E.	NULL
Definitive	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
first	NULL
emerge	NULL
from	NULL
the	NULL
major	NULL
arterial	NULL
regions	NULL
of	NULL
the	NULL
mouse	NULL
embryo	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

2000	NULL
;	NULL
19:2465-2474	NULL
.	NULL

Rubnitz	NULL
JE	NULL
,	NULL
Look	NULL
AT	NULL
.	NULL

Molecular	NULL
basis	NULL
of	NULL
leukemogenesis	NULL
.	NULL

Curr	NULL
Opin	NULL
Hematol	NULL
.	NULL

1998	NULL
;	NULL
5:264-270	NULL
.	NULL

Golub	NULL
TR	NULL
,	NULL
Barker	NULL
GF	NULL
,	NULL
Bohlander	NULL
SK	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Fusion	NULL
of	NULL
the	NULL
TEL	NULL
gene	NULL
on	NULL
12p13	NULL
to	NULL
the	NULL
AML	NULL
1	NULL
gene	NULL
on	NULL
2122	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1995	NULL
;	NULL
92:4917-4921	NULL
.	NULL

Romana	NULL
SP	NULL
,	NULL
Mauchauffe	NULL
M	NULL
,	NULL
Le	NULL
Coniat	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
of	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
results	NULL
in	NULL
a	NULL
tel-AML1	NULL
gene	NULL
fusion	NULL
.	NULL

Blood	NULL
.	NULL

1995	NULL
;	NULL
85	NULL
:	NULL
3662-3670	NULL
.	NULL

Nucifora	NULL
G	NULL
,	NULL
Begy	NULL
CR	NULL
,	NULL
Erickson	NULL
P	NULL
,	NULL
Drabkin	NULL
HA	NULL
,	NULL
Rowley	NULL
JD	NULL
.	NULL

The	NULL
3:21	NULL
translocation	NULL
in	NULL
myelodys-plasia	NULL
results	NULL
in	NULL
a	NULL
fusion	NULL
transcript	NULL
between	NULL
the	NULL
AML1	NULL
gene	NULL
and	NULL
the	NULL
gene	NULL
for	NULL
EAP	NULL
,	NULL
a	NULL
highly	NULL
conserved	NULL
protein	NULL
associated	NULL
with	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
small	NULL
RNA	NULL
EBER	NULL
1	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1993	NULL
;	NULL
90:7784-7788	NULL
.	NULL

Gamou	NULL
T	NULL
,	NULL
Kitamura	NULL
E	NULL
,	NULL
Hosoda	NULL
F	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
partner	NULL
gene	NULL
of	NULL
AML	NULL
1	NULL
in	NULL
t	NULL
(	NULL
16	NULL
;	NULL
21	NULL
)	NULL
myeloid	NULL
malignancies	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
MTG8	NULL
(	NULL
ETO	NULL
)	NULL
family	NULL
.	NULL

Blood	NULL
.	NULL

1998	NULL
;	NULL
91:4028-4037	NULL
.	NULL

Castilla	NULL
LH	NULL
,	NULL
Wijmenga	NULL
C	NULL
,	NULL
Wang	NULL
Q	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Defects	NULL
of	NULL
embryonic	NULL
hematopoiesis	NULL
and	NULL
lethal	NULL
hemorrhaging	NULL
in	NULL
mouse	NULL
embryos	NULL
heterozygous	NULL
for	NULL
a	NULL
knocked-in	NULL
leukemia	NULL
gene	NULL
CBFB-MYH11	NULL
.	NULL

Cell	NULL
.	NULL

1996	NULL
;	NULL
87:687-696	NULL
.	NULL

Kogan	NULL
SC	NULL
,	NULL
Lagasse	NULL
E	NULL
,	NULL
Atwater	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
PEBP2BMYH11	NULL
fusion	NULL
created	NULL
by	NULL
Inv	NULL
{	NULL
16	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
qg22	NULL
)	NULL
in	NULL
myeloid	NULL
leukemia	NULL
impairs	NULL
neutrophil	NULL
maturation	NULL
and	NULL
contributes	NULL
to	NULL
granulocytic	NULL
dys-plasia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1998	NULL
;	NULL
95:11863-11868	NULL
.	NULL

Kanno	NULL
Y	NULL
,	NULL
Kanno	NULL
T	NULL
,	NULL
Sakakura	NULL
C	NULL
,	NULL
Bae	NULL
S-C	NULL
,	NULL
Ito	NULL
Y.	NULL
Cytoplasmic	NULL
sequestration	NULL
of	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
binding	NULL
protein	NULL
2	NULL
(	NULL
PEBP2	NULL
)	NULL
/core	NULL
binding	NULL
factor	NULL
«	NULL
(	NULL
CBFa	NULL
)	NULL
subunit	NULL
by	NULL
the	NULL
leukemia-related	NULL
PEBP2/CBFB-SMMHC	NULL
fusion	NULL
protein	NULL
inhibits	NULL
PEBP2/CBE-mediated	NULL
transactivation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
18:4252-4261	NULL
.	NULL

Adja	NULL
N	NULL
,	NULL
Stacy	NULL
T	NULL
,	NULL
Speck	NULL
NA	NULL
,	NULL
Liu	NULL
PP	NULL
.	NULL

The	NULL
leukemic	NULL
protein	NULL
CBFB-SMMHC	NULL
sequesters	NULL
CBFa2	NULL
into	NULL
cytoskeletal	NULL
filaments	NULL
and	NULL
aggregates	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
18:7432-7443	NULL
.	NULL

Lutterbach	NULL
B	NULL
,	NULL
Hou	NULL
Y	NULL
,	NULL
Durst	NULL
KL	NULL
,	NULL
Hiebert	NULL
SW	NULL
.	NULL

The	NULL
inv	NULL
{	NULL
16	NULL
)	NULL
encodes	NULL
an	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
1	NULL
transcriptional	NULL
corepressor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1999	NULL
;	NULL
96:12822-12827	NULL
.	NULL

Weiss	NULL
MJ	NULL
,	NULL
Orkin	NULL
SH	NULL
.	NULL

In	NULL
vitro	NULL
differentiation	NULL
of	NULL
murine	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

New	NULL
approaches	NULL
to	NULL
old	NULL
problems	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1996	NULL
;	NULL
97:591-595	NULL
.	NULL

Weiss	NULL
MJ	NULL
,	NULL
Keller	NULL
G	NULL
,	NULL
Orkin	NULL
SH	NULL
.	NULL

Novel	NULL
insights	NULL
into	NULL
erythroid	NULL
development	NULL
revealed	NULL
through	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
GATA-1~	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1994	NULL
;	NULL
8:1184-1197	NULL
.	NULL

Weiss	NULL
MJ	NULL
,	NULL
Yu	NULL
C	NULL
,	NULL
Orkin	NULL
SH	NULL
.	NULL

Erythroid-cell-specific	NULL
properties	NULL
of	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
revealed	NULL
by	NULL
phenotypic	NULL
rescue	NULL
of	NULL
a	NULL
gene-targeted	NULL
cell	NULL
line	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1997	NULL
;	NULL
17:1642-1651	NULL
.	NULL

Porcher	NULL
C	NULL
,	NULL
Swat	NULL
W	NULL
,	NULL
Rockwell	NULL
K	NULL
,	NULL
Fujiwara	NULL
Y	NULL
,	NULL
Alt	NULL
FW	NULL
,	NULL
Orkin	NULL
SH	NULL
.	NULL

The	NULL
T-cell	NULL
leukemia	NULL
oncoprotein	NULL
BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

SCL/tal-1	NULL
is	NULL
essential	NULL
for	NULL
development	NULL
of	NULL
all	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Cell	NULL
.	NULL

1996	NULL
;	NULL
86:47-57	NULL
.	NULL

Porcher	NULL
C	NULL
,	NULL
Liao	NULL
EC	NULL
,	NULL
Fujiwara	NULL
Y	NULL
,	NULL
Zon	NULL
L1	NULL
,	NULL
Orkin	NULL
SH	NULL
.	NULL

Specification	NULL
of	NULL
hematopoietic	NULL
and	NULL
vascular	NULL
development	NULL
by	NULL
the	NULL
bHLH	NULL
transcription	NULL
factor	NULL
SCL	NULL
without	NULL
direct	NULL
DNA	NULL
binding	NULL
.	NULL

Development	NULL
.	NULL

1999	NULL
;	NULL
126:4603-4615	NULL
.	NULL

Olson	NULL
M	NULL
,	NULL
Scott	NULL
EW	NULL
,	NULL
Hack	NULL
A	NULL
,	NULL
Su	NULL
G	NULL
,	NULL
Singh	NULL
H	NULL
,	NULL
Simon	NULL
MC	NULL
.	NULL

PU.1	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
early	NULL
myeloid	NULL
gene	NULL
expression	NULL
but	NULL
is	NULL
required	NULL
for	NULL
terminal	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Immunity	NULL
.	NULL

1995	NULL
;	NULL
3:702-714	NULL
.	NULL

Fisher	NULL
RC	NULL
,	NULL
Olson	NULL
MC	NULL
,	NULL
Pongubala	NULL
JMR	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Normal	NULL
myeloid	NULL
development	NULL
requires	NULL
both	NULL
the	NULL
glutamine-rich	NULL
transactivation	NULL
domain	NULL
and	NULL
the	NULL
PEST	NULL
region	NULL
of	NULL
transcription	NULL
factor	NULL
PU.1	NULL
but	NULL
not	NULL
the	NULL
potent	NULL
acidic	NULL
transactivation	NULL
domain	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
18:4347-4357	NULL
.	NULL

Okuda	NULL
T	NULL
,	NULL
Takeda	NULL
K	NULL
,	NULL
Fujita	NULL
Y	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Biological	NULL
characteristics	NULL
of	NULL
the	NULL
leukemia-associated	NULL
transcriptional	NULL
factor	NULL
AML1	NULL
disclosed	NULL
by	NULL
hematopoietic	NULL
rescue	NULL
of	NULL
AML1-deficient	NULL
embryonic	NULL
stem	NULL
cells	NULL
by	NULL
using	NULL
a	NULL
knock-in	NULL
strategy	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

2000	NULL
;	NULL
20	NULL
:	NULL
319-328	NULL
.	NULL

Hawley	NULL
RG	NULL
,	NULL
Lieu	NULL
FHL	NULL
,	NULL
Fong	NULL
AZC	NULL
,	NULL
Hawley	NULL
TS	NULL
.	NULL

Versatile	NULL
retroviral	NULL
vectors	NULL
for	NULL
potential	NULL
use	NULL
in	NULL
gene	NULL
therapy	NULL
.	NULL

Gene	NULL
Ther	NULL
.	NULL

1994	NULL
;	NULL
1:136-138	NULL
.	NULL

Pear	NULL
WS	NULL
,	NULL
Nolan	NULL
GP	NULL
,	NULL
Scott	NULL
ML	NULL
,	NULL
Baltimore	NULL
D.	NULL
Generation	NULL
of	NULL
helper	NULL
free	NULL
retroviruses	NULL
by	NULL
transient	NULL
transfection	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1993	NULL
;	NULL
90	NULL
:	NULL
8392-8396	NULL
.	NULL

Keller	NULL
G	NULL
,	NULL
Kennedy	NULL
M	NULL
,	NULL
Papayannopoulou	NULL
T	NULL
,	NULL
Wiles	NULL
MV	NULL
.	NULL

Hematopoietic	NULL
commitment	NULL
during	NULL
embryonic	NULL
stem	NULL
cell	NULL
differentiation	NULL
in	NULL
culture	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1993	NULL
;	NULL
13:473-486	NULL
.	NULL

Kagoshima	NULL
H	NULL
,	NULL
Akamatsu	NULL
Y	NULL
,	NULL
Ito	NULL
Y	NULL
,	NULL
Shigesada	NULL
K.	NULL
Functional	NULL
dissection	NULL
of	NULL
the	NULL
«	NULL
and	NULL
B	NULL
subunits	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
PEBP2	NULL
and	NULL
the	NULL
redox	NULL
susceptibility	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1996	NULL
;	NULL
271:33074-33082	NULL
.	NULL

Huang	NULL
X	NULL
,	NULL
Crute	NULL
BE	NULL
,	NULL
Sun	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Overexpres-sion	NULL
,	NULL
purification	NULL
,	NULL
and	NULL
biophysical	NULL
characterization	NULL
of	NULL
the	NULL
heterodimerization	NULL
domain	NULL
of	NULL
the	NULL
core-binding	NULL
factor	NULL
6	NULL
subunit	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
273	NULL
:	NULL
2480-2487	NULL
.	NULL

Okuda	NULL
T	NULL
,	NULL
Cai	NULL
Z	NULL
,	NULL
Yang	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
knocked-in	NULL
AML1-ETO	NULL
leukemia	NULL
gene	NULL
inhibits	NULL
the	NULL
establishment	NULL
of	NULL
normal	NULL
definitive	NULL
hematopoiesis	NULL
and	NULL
directly	NULL
generates	NULL
dysplastic	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

Blood	NULL
.	NULL

1998	NULL
;	NULL
91:3134-3143	NULL
.	NULL

Huang	NULL
X	NULL
,	NULL
Peng	NULL
JW	NULL
,	NULL
Speck	NULL
NA	NULL
,	NULL
Bushweller	NULL
JH	NULL
.	NULL

Solution	NULL
structure	NULL
of	NULL
core	NULL
binding	NULL
factor	NULL
B	NULL
and	NULL
map	NULL
of	NULL
the	NULL
CBFa	NULL
:	NULL
binding	NULL
site	NULL
.	NULL

Nat	NULL
Struct	NULL
Biol	NULL
.	NULL

1999	NULL
;	NULL
6:624-627	NULL
.	NULL

Goger	NULL
M	NULL
,	NULL
Gupta	NULL
V	NULL
,	NULL
Kim	NULL
W-Y	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Ito	NULL
Y	NULL
,	NULL
Werner	NULL
MH	NULL
.	NULL

Molecular	NULL
insights	NULL
into	NULL
PEBP2/	NULL
CBFB-SMMHC	NULL
associated	NULL
acute	NULL
leukemia	NULL
revealed	NULL
from	NULL
the	NULL
three-dimensional	NULL
structure	NULL
of	NULL
PEBP2/CBFB	NULL
.	NULL

Nat	NULL
Struct	NULL
Biol	NULL
.	NULL

1999	NULL
;	NULL
6:620-623	NULL
.	NULL

Castilla	NULL
LH	NULL
,	NULL
Garrett	NULL
L	NULL
,	NULL
Adya	NULL
N	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Chromosome	NULL
16	NULL
inversion-generated	NULL
fusion	NULL
gene	NULL
Cbfb-MYH11	NULL
blocks	NULL
myeloid	NULL
differentiation	NULL
and	NULL
predisposes	NULL
mice	NULL
to	NULL
acute	NULL
myelomonocytic	NULL
leukemia	NULL
.	NULL

Nat	NULL
Genet	NULL
.	NULL

1999	NULL
;	NULL
23:144-146	NULL
.	NULL

Yergeau	NULL
DA	NULL
,	NULL
Hetherington	NULL
CJ	NULL
,	NULL
Wang	NULL
Q	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Embryonic	NULL
lethality	NULL
and	NULL
impairment	NULL
of	NULL
hematopoiesis	NULL
in	NULL
mice	NULL
heterozygous	NULL
for	NULL
an	NULL
AML1-ETO	NULL
fusion	NULL
gene	NULL
.	NULL

Nat	NULL
Genet	NULL
.	NULL

1997	NULL
;	NULL
15:303-306	NULL
.	NULL

North	NULL
T	NULL
,	NULL
Gu	NULL
T-L	NULL
,	NULL
Stacy	NULL
T	NULL
,	NULL
et	NULL
al	NULL
.	NULL

CbfaZ	NULL
is	NULL
required	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
intraaortic	NULL
hematopoietic	NULL
clus-ters	NULL
.	NULL

Development	NULL
.	NULL

1999	NULL
;	NULL
126:2563-2775	NULL
.	NULL

Osato	NULL
M	NULL
,	NULL
Asou	NULL
N	NULL
,	NULL
Abdalla	NULL
E	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Biallelic	NULL
and	NULL
heterozygous	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
Runt	NULL
domain	NULL
of	NULL
the	NULL
AML1/PEBP2aB	NULL
gene	NULL
associated	NULL
with	NULL
my-eloblastic	NULL
leukemias	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93:1817-1824	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
2001	NULL
97	NULL
:	NULL
2248-2256	NULL
doi:10.1182/blood.V97.8.2248	NULL
Core-binding	NULL
factor	NULL
B	NULL
(	NULL
CBF	NULL
$	NULL
B	NULL
)	NULL
,	NULL
but	NULL
not	NULL
CBFB-smooth	NULL
muscle	NULL
myosin	NULL
heavy	NULL
chain	NULL
,	NULL
rescues	NULL
definitive	NULL
hematopoiesis	NULL
in	NULL
CBF	NULL
B-deficient	NULL
embryonic	NULL
stem	NULL
cells	NULL
o	NULL
)	NULL
A	NULL
--	NULL
0	NULL
%	NULL
A	NULL
,	NULL
8	NULL
%	NULL
o	NULL
p	NULL
'	NULL
c	NULL
Eh	NULL
)	NULL
``	NULL
I	NULL
f	NULL
C108	NULL
\	NULL
e	NULL
Janelle	NULL
D.	NULL
Miller	NULL
,	NULL
Terry	NULL
!	NULL

Stacy	NULL
,	NULL
P.	NULL
Paul	NULL
Liu	NULL
and	NULL
Nancy	NULL
A.	NULL
Speck	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/97/8/2248.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

